Mapping RNA Binding Surfaces on Hfq Using Tryptophan Fluorescence Quenching by Hoff, Kirsten E.
  
 
 
 
Mapping RNA Binding Surfaces on Hfq Using Tryptophan Fluorescence Quenching 
by 
Kirsten Else Hoff 
Department of Biochemistry 
Duke University 
 
Date:_______________________ 
Approved: 
 
___________________________ 
Richard G. Brennan, Supervisor 
 
___________________________ 
Jack D. Keene 
 
___________________________ 
David C. Richardson 
 
___________________________ 
Pei Zhou 
 
 
Dissertation submitted in partial fulfillment of 
the requirements for the degree of Doctor of Philosophy in the Department of 
Biochemistry in the Graduate School 
of Duke University 
 
2013 
 
 
 
  
ABSTRACT 
Mapping RNA Binding Surfaces on Hfq Using Fluorescence Quenching 
by 
Kirsten Else Hoff 
Department of Biochemistry 
Duke University 
 
Date:_______________________ 
Approved: 
 
___________________________ 
Richard G. Brennan, Supervisor 
 
___________________________ 
Jack D. Keene 
 
___________________________ 
David C. Richardson 
 
___________________________ 
Pei Zhou 
 
 
An abstract of a dissertation submitted in partial 
fulfillment of the requirements for the degree 
of Doctor of Philosophy in the Department of 
Biochemistry in the Graduate School 
of Duke University 
 
2013 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Kirsten Else Hoff 
2013 
 
  
iv 
Abstract 
 Hfq is a pleiotropic posttranscriptional regulator and RNA chaperone that 
facilitates annealing of trans-encoded sRNA/mRNA pairs.  It regulates many different 
cellular pathways including environmental stress responses, quorum sensing, virulence 
and maintenance of membrane integrity.  Hfq is a member of the Sm/LSm family and 
forms a homohexamer that has two faces, termed proximal and distal.  Hfq 
preferentially binds A/U rich regions that are near stem loop structures.  Crystal 
structures have shown that poly-A sequences tend to bind the distal face while poly-U 
sequences bind the proximal face.  Currently crystal structures reveal the binding 
mechanisms for short RNA sequences however; physiologically relevant RNA 
sequences are typically longer and more structured.  To study how these more complex 
RNA sequences interact with Hfq, a tryptophan fluorescence quenching (TFQ) assay has 
been developed.  Here it is presented that TFQ can correctly identify the binding face for 
two control sequences, A15 and U6, using the E. coli, S. aureus and L. monocytogenes Hfq 
homologues.  Using fluorescence anisotropy and crystallography it is observed that Trp 
mutants necessary for TFQ may affect binding to some degree but do not affect the 
overall structure or RNA binding function of Hfq.  TFQ is then used to examine the 
distal face binding motifs for both Gram-negative (E. coli) and Gram-positive (S. 
aureus/L. monocytogenes) Hfq, (A-R-N)n and (R-L)n respectively.  Using sequences that 
  
v 
either fulfilled just (A-R-N)n or both (A-R-N)n and (A-A-N)n motifs it is shown that the 
distal face motif for Gram-negative Hfq is the more specific (A-A-N)n motif.  Using 
sequences that either fulfilled just (R-L)n or both (R-L)n and (A-L)n motifs it is shown that 
the Gram-positive distal face motif can be redefined to the (A-L)n motif.  Finally TFQ is 
used to explore autoregulation of E. coli hfq.  Two identified binding sites located in the 
5’ UTR of hfq mRNA, site A and site B, were used for TFQ, along with a longer RNA 
sequence that contains both sites and their native linker, 5’ UTR.  TFQ illustrates that the 
individual sites and the 5’ UTR are capable of binding both faces.  Each site appears to 
prefer binding to one face over the other, suggesting a model for hfq 5’ UTR mRNA 
binding to Hfq where either one or two hfq mRNA bind a single Hfq hexamer.  In 
conclusion, TFQ is a straightforward method for analyzing how RNA sequences interact 
with Hfq that can be utilized to study how longer, physiologically relevant RNA 
sequences bind Hfq.   
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1. Introduction 
 
1.1 Function of Hfq 
Escherichia coli (E. coli) Host Factor required for phage Qβ protein RNA 
Replication (Hfq) was originally identified as a factor required for replication of the 
RNA plus strand of bacteriophage Qβ (1-3).  It has since been shown that disruption of 
the hfq gene causes pleiotropic effects in many bacterial species including E. coli (4), 
Listeria monocytogenes (L. monocytogenes) (5, 6), Sinorhizobium meliloti (S. meliloti) (7), 
Borellia burgdorferi (B. burgdorferi) (8), Neisseria gonorrhoeae (N. gonorrhoeae) (9) and others.  
Some of the observed phenotypes include cell length increases, growth rate decreases, 
and sensitivity to environmental stressors.   Hfq is known to be an essential virulence 
factor in E. coli, Salmonella typhimurium (S. typhimurium), Pseudomonas aeruginosa (P. 
aeruginosa), Vibrio cholerae (V. cholerae) and other bacteria (10-14).  Recently Hfq has been 
observed to be involved in the multidrug resistance mechanisms of E. coli and Salmonella 
enterica (S. enterica) serovar typhimurium (15, 16).  This resistance is conferred by Hfq 
regulation of the AcrB drug efflux pump in E. coli (15) and the SmvA drug efflux pump 
in S. enterica (16).  
Hfq has also been shown to play a critical role in many different cellular 
pathways including cellular response to multiple environmental stressors, maintenance  
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Figure 1: Known Hfq Mechanisms of Action 
A) Hfq bound to a sRNA may then sequester the ribosome binding site (RBS) of 
the target mRNA thus preventing the ribosomal subunits from binding, 
preventing translation. B)  Some mRNA strands have a secondary structure in 
the 5’ untranslated region (5’ UTR) that blocks the RBS and prevents translation.  
When Hfq binds to a sRNA it can then bind to the mRNA to prevent formation 
of the secondary structure thus allowing translation. C) Hfq may protect some 
sRNAs from being degraded by RNase E by binding to the sRNA.  D) Hfq 
forming a sRNA/mRNA pair may lead to degradation of the sRNA/mRNA pair 
by RNase E thus leading to downregulation of the mRNA. E) Hfq may bind an 
mRNA strand and promote polyadenylation by poly(A) polymerase (PAP) 
which then leads to 3’-5’ degradation by an exoribonuclease thus leading to 
downregulation. Figure is taken from (17). 
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of membrane integrity, virulence, and quorum sensing.  Hfq functions through 
controlling expression of targeted genes posttranscriptionally by binding to short 
stretches of A/U rich regions in small noncoding RNAs (sRNA) and messenger RNA 
(mRNA).  The mechanism of Hfq action usually involves binding a sRNA and 
facilitating the annealing of that sRNA to its target mRNA.  This sRNA/mRNA pairing 
leads to either upregulation or, more likely, downregulation of the targeted mRNA 
(Figure 1).  There are several different interactions that can happen between sRNA, 
mRNA and Hfq as can be seen in Figure 1.   To upregulate translation, Hfq can bind to a 
sRNA that pairs with a mRNA and removes a translation inhibitory secondary structure 
thus allowing ribosomal access to the Shine/Delgarno sequence and promoting 
translation (18, 19) (Figure 1B).  Hfq can downregulate translation by binding to a 
sRNA/mRNA pair in a way that blocks the ribosome from the Shine/Delgarno sequence 
thus preventing translation (see Figure 1A). It can also bind to a sRNA/mRNA pair 
which then promotes degradation of the pair by RNase E (20-22) (see Figure 1D) or Hfq 
can bind to an mRNA, promote poly(A) polymerase to polyadenylate the 3’ end of the 
mRNA sequence which then leads to 3’-5’ degradation of the mRNA by an exonuclease 
thus leading to decreased expression (23, 24) (see Figure 1E).  Finally, Hfq can bind to 
sRNA to sequester it from the cell and prevent degradation of the sRNA which could 
promote both up and downregulation (Figure 1C) 
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Facilitating the trans sRNA-mRNA pairings has led to Hfq being termed an RNA 
chaperone.   A detailed understanding of how these different mechanisms are 
influenced by Hfq is essential to understanding how Hfq functions and potentially 
developing Hfq as a drug target.  The number of genes whose expression is affected by 
Hfq varies between bacterial species. However, it tends to range from 5-25% of all genes 
within a species (13, 25-27).  This large number of genes requires a large collection of 
sRNA and mRNA sequences be present to ensure proper regulation.  Most trans-encoded 
sRNA/mRNA pairs require a helper protein, in bacteria this is most often Hfq.  Hfq is at 
a relatively low concentration compared to the sRNA/mRNA pool concentration in vivo.  
However, the time span between when a sRNA is induced and when major effects are 
observed from that induction is short at 1-2 min (20, 28).  
Hfq has been shown to preferentially bind to A/U-rich strands of RNA.  Most 
sRNA, mRNA and artificial RNA sequences that have been tested for Hfq binding have 
high affinities, typically ranging from sub- to mid- nM KD’s.  As such, a model for how 
Hfq manages to interact with all these different RNA sequences simultaneously has been 
hypothesized that is known as the “Active Cycling” model (29, 30).  In this model it is 
proposed that since the Hfq-RNA complex has a low dissociation rate the driver of RNA 
exchange is the free RNA pool, implying that release of RNA from Hfq follows second 
order kinetics (Figure 2).  Bound RNA contacts several Hfq subunits while a free 
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competitor RNA contacts a single unoccupied subunit on the same face as the bound 
RNA.  Through a series of reversible steps the competitor RNA can swap with the 
bound RNA.  It has been observed that the dissociation rate constant for an Hfq-RNA  
 
Figure 2: Current Proposed Cycling Models for Hfq 
Two current models for how Hfq cycles through different RNA.  A) The “passive 
cycling” model requires that the Hfq-RNA pair dissociate before another free 
(red) RNA can bind to Hfq. B) The “active cycling” model shows that the free 
RNA will bind to the Hfq-RNA complex and then potentially lead to dissociation 
of the bound (blue) RNA, depending on the second order association rate 
constant and free RNA concentration. Figure is taken from (30). 
complex will dramatically increase in the presence of a competitor RNA, dropping from 
a rate of >150 min down to 1-5 min (31), which adjusts the rate of RNA exchange on Hfq 
to within the observed in vivo rates (20, 28), strongly supporting the active cycling 
model. 
Hfq has been shown to interact with many different sRNA/mRNA pairs 
including DsrA-rpoS, RhyB-sodB, Spot42-galK, SgrS-ptsG and others.  These RNA pairs 
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regulate a variety of different cellular mechanisms.  For example the sRNA DsrA binds 
to the 5’ UTR region of rpoS mRNA, thus preventing an inhibitory secondary structure 
and allowing translation of RpoS to occur (Figure 1B).  RpoS regulates stationary phase 
genes and is important for stress response to environmental factors such as UV 
radiation, osmotic or temperature shock, oxidative stress, acid or nutrient deprivation.  
Another sRNA/mRNA pair that Hfq aids formation of is the RhyB/sodB pair.  RhyB will 
bind to sodB and downregulate the level of sodB in the cell.  SodB encodes superoxide 
dismutase, which catalyzes the dismutation of superoxide into oxygen and hydrogen 
peroxide.  RhyB is an example of a sRNA that binds and downregulates many different 
mRNA transcripts via Hfq mediation including the mRNAs for iron storage and iron 
usage proteins, all mRNAs found in the sdhCDAB operon, which encodes succinate 
dehydrogenase, and others.  These pairs are just two examples of the many different 
sRNA/mRNA pairs that are regulated by Hfq and mediate many cellular functions 
including stress response, membrane integrity, virulence, drug resistance and quorum 
sensing.  Understanding the structural and biochemical basis of how Hfq manages to 
chaperone all of these RNA interactions will improve our knowledge of how these 
pathways function and enable studies on regulating Hfq-RNA interactions for 
developing as a potential drug target.  
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1.2 Crystal Structures of Hfq 
Hfq is a member of the Sm/LSm family (32, 33).  This family of proteins contains 
both eukaryotic and prokaryotic members.  Hfq has been identified in ~50% of all 
sequenced bacteria and has a highly conserved N-terminus (residues 1-69) while the C-
terminal tail is highly variable in both length and sequence (Figure 3).  For example, E. 
coli Hfq has a 30 residue C-terminal tail whereas S. aureus Hfq only has 9 residues in its 
C-terminus.  The N-terminus has been shown to function without the C-terminus and 
the role of the C-terminus is still being determined (34, 35).   
 
Figure 3: Sequence Alignment of Hfq Homologues 
This alignment shows that the N-terminal core is highly conserved while the C-
terminus is highly variable in length and sequence. Taken from (36).   
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Figure 4: Hfq Greek Key and Monomeric Structure 
The secondary and tertiary structure of a Hfq monomer showing the Sm-1, β-
strands 1-3, and Sm-2, β-strands 4-5, motifs.  Taken from (37).   
 
All members of the Sm/LSm family have a similar monomeric fold that consists 
of an N-terminal α-helix followed by a five-stranded twisted anti-parallel β-sheet 
(Figure 4).  There are two structural motifs present in the monomer termed Sm-1 and 
Sm-2.  Sm-1 is composed of the first three β-strands while Sm-2 contains the last two β-
strands, which are located on opposite sides of the body of the Hfq protomer (Figure 4).  
The eukaryotic members of the Sm/LSm family typically form a heteroheptameric 
toroidal shape that has a pore in the middle of the ring.  All prokaryotic Sm/LSm family 
members are Hfq homologues.  
The first apo crystal structure of a prokaryotic Hfq protein was that of S. aureus 
Hfq (38).  This structure showed that Hfq forms a homohexameric toroidal ring that 
 9 
 
orients the N-terminal α-helices all on one face of the ring (Figure 5).  Since the α-helices 
are all found to be on one face, the two faces can be distinguished from each other and 
 
Figure 5: WT S. aureus Hfq Apo Crystal Structure 
Image made using Pymol from PDB 1KQ1 (38).  Hfq is a homohexamer that takes 
on a toroidal ring structure with all α-helices on one face. 
 
are termed the proximal (α-helix) and distal faces (Figure 5).  The E. coli Hfq homologue, 
which also has a described apo structure (39), has a 30 residue C-terminus (compared to 
S. aureus Hfqs’ C-terminal tail of 9 residues) however,  attempts to observe the C-
terminal tail by high-resolution x-ray crystallography have been unsuccessful (40).  The 
observed apo structure for E. coli is similar to S. aureus with alignment of the hexamers 
giving an RMSD of 0.90 Å. 
There have also been several x-ray crystallography structures solved of Hfq 
homologues bound to RNA.  The first bound structure was of S. aureus Hfq-AU5G (38).  
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In this structure the RNA sequence was found to be bound in a circular fashion within 
the pore formed on the proximal face by the α-helices (Figure 6).   A single nucleotide is 
 
Figure 6: S. aureus Hfq-AU5G Crystal Structure 
The structure of S. aureus Hfq-AU5G.  RNA binds within the pore on the 
proximal face.  The pocket that binds to adenosine and a uridine binding pocket 
are zoomed in to show contacts.  RNA is colored blue while Hfq is colored light 
green.  The side chains are colored by atom type with C = light blue (RNA)/green 
(Hfq), O = red, N = blue. Images made in Pymol using PDB 1KQ2 (38). 
 
shown to be bound per protomer with the adenosine and uridine nucleosides bound 
while the guanosine points into the pore (Figure 6).  The uridines and single adenosine 
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are shown to be base stacking with residue tyrosine (Y) 42.  Cytosine and guanosine 
appear to be discriminated against by residues lysine (K) 41, K57 and glutamate (E) 8 
however these binding sites can accommodate both uridine and adenosine as is seen in 
the structure (Figure 6).  There are three other structures of Hfq homologues bound to 
RNA on the proximal face, E. coli Hfq-AU6A (41), E. coli A7-Hfq-AU6A (42) and 
S.typhimurium Hfq-U6 (43).  Overall these structures show a similar binding mode to S. 
aureus Hfq–AU5G with slight differences.  They all show base stacking with adjacent 
aromatic residues and base specificity conferred mainly by hydrogen bonds between the 
base and either side chain or backbone atoms of nearby residues.   
There are also several structures of Hfq bound to RNA on the distal face.  These 
structures include E. coli Hfq-A15 (44), E.coli Hfq-A7 (42), E. coli A7-Hfq-AU6A (42), 
Bacillus subtilis (B.subtilis) Hfq-(AG)3A (45) and S. aureus Hfq-A4 (46).  These structures 
show two different binding motifs depending on whether the Hfq homologue is from a 
Gram-negative or Gram-positive bacterium.  The E. coli Hfq-A15 structure shows a 
circularly bound RNA with three nucleotides bound per protomer subunit in an (A-R-
N)n binding motif where A = adenosine, R = any purine nucleoside and N = any 
nucleoside (Figure 7).  The A-site specificity of E. coli Hfq is conferred by peptide 
backbone amide and carbonyl oxygen hydrogen bonding between residue Q33 and the 
N7 and N6 atoms of adenine and a polar interaction between the Nε amide of residue  
 12 
 
 
Figure 7: E. coli Hfq-A15 Crystal Structure 
The crystal structure of E. coli Hfq-A15.  RNA binds to the distal face in an (A-R-
N)n motif where A = adenine nucleoside, R = any purine nucleoside, N = any 
nucleoside.  Both the A- and R-sites are zoomed in to show contacts.  RNA is 
colored blue while Hfq is colored light green.  The side chains are colored by 
atom type with C = light blue (RNA)/green (Hfq), O = red, N = blue.  The images 
were made in Pymol using PDB 3GIB (44). 
 
Q52 and the adenine N1 atom (Figure 7).  The R-site of E. coli Hfq appears to be able to 
accommodate both adenosine and guanosine whereby the purine ring sticks into a 
pocket and packs against residues Y25, leucine (L) 26, isoleucine (I) 30 and L32.  The 
adenosine N3, N6, N1 and ribosyl 2' hydroxyl atoms hydrogen bond to Nδ of residue 
N28, Oε atom of residue Q52, Oγ of residue T61, and the carbonyl oxygen of residue  
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Figure 8: S. aureus Hfq-A4 Crystal Structure 
The crystal structure of S. aureus Hfq-A4.  RNA binds to the distal face in an (R-
L)n motif where R = any purine nucleoside, L = R-site linker nucleoside.  Both the 
R- and L-sites are zoomed in to show contacts.  RNA is colored blue while Hfq is 
colored light green.  The side chains are colored by atom type with C = light blue 
(RNA)/green (Hfq), O = red, N = blue.  The images were made in Pymol using 
PDB 3QSU (46). 
 
glycine (G) 29, respectively.  The N site has no protein-nucleic acid interactions and 
likely represents the entrance or exit point for RNA.   
By contrast, the B. subtilis Hfq-(AG)3A and S. aureus Hfq-A4 complex structures 
show a significantly different distal-face binding mode, the so named (R-L)n binding 
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motif, where R = any purine nucleoside and L = R-site linker nucleoside and can be any 
base (Figure 8).  The R-site is located between β strands 2 and 2’ of adjacent subunits, 
where the prime indicates the adjacent subunit.  The R-site specificity is conferred by 
base stacking with phenylalanine (F) 25, F26’ and F30’ along with making van der Waals 
contacts with L27’ and methionine (M) 32’, where the prime indicates the adjacent 
subunit. There are also selective hydrogen bonds from N28’ to the sugar O4’ and 
adenine N3 nitrogen, the carbonyl oxygen of G29 to the 2’-OH and between the N1 atom 
and exocyclic N6 amino group of adenine to the hydroxyl groups of serine (S) 61 and 
threonine (T) 62. The L-site adenosine base stacks with Q31.  The peptide amide of Q31 
hydrogen bonds to the sugar O4’. Consequently, the R sites of the E. coli, B. subtilis and 
S. aureus Hfqs are equivalent but not identical and the mode of protein-nucleobase 
stacking differs.  However, the altered sequences also preclude the formation of the A-
site in the B. subtilis or S. aureus Hfq proteins (46). 
On Gram-positive Hfq the (R-L)n binding motif presents 12 possible binding sites 
per hexamer versus the possibility of 18 binding sites for the (A-R-N)n motif in Gram-
negative Hfq (46). The presence of an (A-R-N)n or an (R-L)n binding mode can be 
attributed to conserved sequence differences between Hfqs from Gram-negative and 
Gram-positive bacteria (46).. Consequently, the R sites of the E. coli, B. subtilis and S. 
aureus Hfqs are equivalent but not identical and the mode of protein-nucleobase 
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stacking differs modestly.  However, the altered sequences also preclude the formation 
of the A-site in the B. subtilis or S. aureus Hfq proteins (46). 
Recently the first structure of Hfq bound to two RNAs simultaneously has been 
reported.  The solved structure is of WT E.coli Hfq bound to A7 and AU6A (A7-Hfq-
AU6A) (42).  In this structure it is observed that the overall binding for A7 is similar to 
the Hfq-A15 structure.  Of more interest is the observation that only 4 uridines, rather 
than the expected six, are found in the expected proximal face binding pockets while the 
other nucleotides are not resolved in the structure.  It is hypothesized that having RNA 
bound on the distal face causes structural changes that destabilizes binding on the 
proximal face.  However, understanding exactly what those changes are will require 
further studies as the current structures do not illustrate what has changed to destabilize 
proximal face binding.  An overlay of A7-Hfq-AU6A with the corresponding singly 
bound Hfq-A15 or Hfq-AU6A structures yields RMSDs of 0.62 Å and 0.87 Å respectively 
(Figure 9).  These alignments indicate a high similarity between the structures thus not 
yielding any obvious explanation for why the bound uridine nucleotide is not seen to 
bind fully to the hexamer. 
 16 
 
 
Figure 9: Alignment of A7-Hfq-AU6A with Hfq-A15 and Hfq-AU6A 
Alignment of crystal structures.  A7-Hfq-AU6A (PDB ID: 4HT9) to Hfq-A15 (PDB 
ID: 3GIB) yields an RMSD of 0.62 Å while A7-Hfq-AU6A to Hfq-AU6A (PDB ID: 
3RER) yields an RMSD of 0.87 Å.  RMSD calculations were done using secondary 
structure matching and C atom alignment via SSM superpose (47). Images were 
created using Pymol (48). 
All of these structures provide excellent insight into how Hfq homologues bind 
various short RNA sequences.  However, these structures all use either truncated 
variants of Hfq (E. coli) or have a naturally short C-terminal tail and thus do not provide 
information on the structure or role of the highly variable C-terminal region of Hfq.  
Structures using the full length E. coli Hfq homologue do not have density for the C-
 17 
 
terminus suggesting that the C-terminal tail is highly flexible for apo Hfq (40).  
Currently the role of the C-terminal tail is poorly understood with some studies 
indicating that the C-terminus interacts with RNA (34) while other reports indicate that 
the tail is not important for Hfq function (35).  These structures also use RNA sequences 
that are short pieces of what are typically much larger RNA sequences in vivo and 
therefore the structures may not tell a complete story for how Hfq functions within its 
native environment. 
1.3 Small Angle X-ray Scattering of Hfq 
Recently a few small angle x-ray scattering (SAXS) studies on full length Hfq 
homologues in both apo and RNA bound forms have been performed.  These studies 
provide envelopes for full length apo Vibrio cholerae (V. cholerae) and apo E. coli Hfq (36),  
E. coli Hfq-DsrA34 sRNA (49) and of V. cholerae Hfq-Qrr1 sRNA (50).  The full length apo 
Hfq SAXS envelopes indicate that with six-fold symmetry the protein takes on a six 
pointed star shape with full length E. coli Hfq having longer points than full length V. 
cholerae Hfq as would be expected since E. coli has a longer C-terminal tail (36).   
Modeling the crystal structure of the N-terminal core of E. coli Hfq into the envelope 
shows that the N-terminal core sits in the middle of the star, leaving the points of the 
star as the location of the C-terminal tail (Figure 10A).   
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Figure 10: SAXS Envelopes of Apo and Bound Hfq 
A) The full length (FL) apo E. coli envelope (36) shows a six pointed star where 
the Hfq core resides in the center and the C-terminus is located in the points.  
The bound envelopes both show RNA bound on one face.  B) V. cholerae Hfq-
Qrr1 complex(50) and apo Qrr1. Other experiments were performed to identify 
the proximal face as the site of Qrr1 binding C) E. coli Hfq-DsrA34 complex (49). 
NMR experiments indicate that DsrA34 binds on the proximal face. This figure is 
adapted from figures in (36, 49, 50). 
 
The SAXS envelope calculated for V. cholerae Hfq-Qrr1 sRNA shows that Hfq is 
capable of changing the structure of Qrr1 upon binding and that a single Qrr1 sRNA is 
bound to an Hfq hexamer (Figure 10B) (50).  The SAXS envelope also shows that the 
Qrr1 sRNA is bound straight across one face of the Hfq hexamer, which was determined 
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to be the proximal face based on gel shift assays that were performed using proximal 
and distal face null mutants, which are the point mutants K56A and Y25D, respectively 
and are designed to knockout RNA binding on that face (50).  This result is particularly 
interesting in that the Qrr1 sRNA does not appear to bind in a circular manner on the 
proximal face as has been shown to be the case in all x-ray structures of Hfq bound to 
RNA on the proximal face.  This SAXS envelope also shows some potential interaction 
between the c-terminal residues of Hfq and the Qrr1 RNA suggesting that the presence 
of the c-terminus may play a role in RNA binding (50). 
 The final calculated envelope is for E. coli Hfq-DsrA34 sRNA (49) which shows a 
single RNA strand bound to one Hfq hexamer.  This envelope shows DsrA34 binding in a 
non-circular manner on one face of the Hfq hexamer.  Through nuclear magnetic 
resonance (NMR) spectroscopy 1H-15N heteronuclear single quantum coherence (HSQC) 
and 1H-13C HSQC titration experiments it was determined DsrA34 binds the proximal 
face.  Specifically, three clusters of residues were observed to experience a change in 
their environment: 1) the YKH motif (residues 56-58) located in the central pore of the 
proximal face and the neighboring residues in the adjacent β-strands, 2) the N-terminal 
residues 2-4 which became structured extending the α-helix on the proximal face, and 3) 
residues 34-37 that are located in the loop following the β2 strand (49).   These NMR 
observations are in agreement with mutational studies that have also indicated that 
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DsrA binds to the proximal face (51).  This study concludes that the C-terminus of E. coli 
Hfq does not interact with DsrA34, which is in contrast to what was observed for V. 
cholerae Hfq-Qrr1. 
These SAXS studies show that the full length apo structure of Hfq forms a six 
pointed star with the N-terminal core located in the middle of the envelope and the C-
terminus extending out the points.  They also show a 1:1 RNA:Hfq hexamer binding 
pattern and that the bound RNA does not bind in a circular manner as would be 
suggested by the known crystal structures.  This disparity can easily be explained by the 
differences between the RNA sequences used to obtain the crystal structures versus the 
sequences used for SAXS.  The RNA sequences in the crystal structures are much shorter 
sequences ranging from 6-8 nucleotides for binding to the proximal face and 7-15 for 
binding to the distal face while the SAXS sequences are 34, DsrA34 and 99, Qrr1, 
nucleotides long.  The two bound SAXS envelopes reach opposing conclusions on the 
role of the C-terminus which may be due to differences between the two Hfq 
homologues or may be due to differences in the RNA sequence lengths.  This disparity 
suggests that further study on the role of the C-terminus is necessary.  It is also noted the 
SAXS studies of Hfq bound to RNA both used sRNA sequences and found binding on 
the proximal face.  It is of interest to also study mRNA interactions with Hfq and 
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determine if physiologically relevant mRNA sequences bind the distal face as is 
hypothesized. 
1.4 Outstanding Questions to be Answered 
Hfq has many different pathways that it regulates through its RNA chaperone 
activity.  It is well known that Hfq functions by facilitating the annealing of 
sRNA/mRNA pairs.  While this function is well known, how Hfq facilitates RNA 
annealing, while studied for short RNA sequences, is not well understood for longer, 
more physiologically relevant RNA sequences.  The aforementioned crystal structures 
all illustrate how Hfq interacts with short RNA sequences, which do come from 
physiologically relevant RNA sequences but do not necessarily show how a full length 
in vivo RNA sequence binds Hfq.  The SAXS envelopes also provide information about 
how an RNA sequence interacts with Hfq.  However, SAXS envelopes are low resolution 
and cannot provide detailed interaction information.  In order to know which face an 
RNA sequence is binding to in a SAXS envelope other experiments must be conducted, 
such as NMR titrations or gel shift assays.  Thus while there is now strong evidence that 
Hfq can bind RNA on its two faces, along with a third lateral binding site that has been 
identified only by size exclusion chromatography (52), there is a dearth of information 
on how Hfq binds to longer, physiologically relevant RNA sequences.  Are these longer 
sequences capable of wrapping around Hfq thus leading to the observed structural 
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changes?  Does the C-terminal tail of Hfq interact with RNA and, if it does, is that 
interaction important?  Currently the role of the highly variable C-terminal tail is poorly 
understood with some data indicating that the tail does interact with RNA (34) while 
other data indicate that the tail is not important for Hfq function (35).  Are the current 
distal face binding motifs correct?   
To address some of these questions tryptophan fluorescence quenching (TFQ) 
methodology has been developed.  TFQ utilizes the fact that E. coli, S. aureus and Listeria 
monocytogenes (L. monocytogenes) Hfq homologues do not have native tryptophan (Trp).  
Trp fluoresces and using structure-guided design it is possible to place Trp mutants 
throughout Hfq.  RNA will quench the Trp fluorescence of these Hfq Trp mutants, thus 
addition of RNA that interacts with the Trp mutant will cause a loss of fluorescence, 
known as TFQ.  TFQ correctly identifies the binding surfaces for control sequences A15 
and U6.  Using TFQ the proposed distal face binding motifs for Gram-negative and 
Gram-positive bacteria are examined and have been determined to be refined from (A-
R-N)n and (R-L)n motifs to (A-A-N)n and (A-L)n motifs, respectively.  This restriction of 
the distal face binding motif has been previously hypothesized (46) due to the fact that 
all relevant crystal structures have an adenosine bound in the R-site. However, to date 
no technique has been able to definitively demonstrate that the relevant distal face 
binding motifs are the more restricted (A-A-N)n and (A-L)n motifs.  Finally, using TFQ it 
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is shown that E. coli Hfq binds to the previously identified sites from hfq mRNA.  These 
two sites are both capable of binding to both faces of Hfq with each RNA binding site 
demonstrating a preference for one face.  A longer sequence (64 nt) from hfq mRNA that 
contains both binding sites also binds to both faces and is the only sequence observed by 
TFQ to bind to the recently identified lateral binding site.  For many tested RNA 
sequences TFQ is observed for residues that are located throughout the C-terminal tail 
indicating that it interacts with RNA.   
 Thus, herein is described a robust method for mapping the binding location of 
small and reasonably large RNAs.  This approach should find wide applicability with 
Hfq from multiple species.  This approach may also be applicable to studying Hfq-
protein interactions as long the proteins of interest do not contain Trp.
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2. Tryptophan Fluorescence Quenching Correctly 
Identifies RNA Interaction Surfaces on Hfq 
2.1 Tryptophan Fluorescence and Fluorescence Quenching 
Fluorescence occurs when an electron in a molecule is excited by a photon that 
exactly matches the energy required to excite that electron causing the electron to leave 
the ground state and move into an excited state.  Immediately after excitation the  
 
Figure 11: Jablonski Diagram (53). 
The Jablonski diagram illustrates how an electron in the ground state is excited 
by an absorbed photon, moves into an excited state and then releases the 
absorbed energy as fluorescent light and returns to the ground state (53). 
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electron releases absorbed energy as either light, heat or to do chemical work and 
returns to the original ground state (Figure 11).  Fluorescence is the emitted light as the 
electron returns to the ground state and is always at a longer wavelength than the 
absorbed photon. Many biological molecules fluoresce, including reduced nicotinamide 
dinucleotide (NADH), chlorophyll, pyridoxal phosphate and proteins (54).  Within 
proteins the aromatic amino acids phenylalanine (Phe, F), tyrosine (Tyr, Y) and Trp (W) 
are known to be fluorescent.  The strongest fluorophore is Trp while Phe has the lowest 
quantum yield (54).  It is possible to selectively excite Trp by using wavelengths above 
295 nm as the other aromatic residues are not excited at these wavelengths (54).  
Fluorescence is sensitive to its environment and will be affected by changes in polarity, 
salt, pH and for protein fluorescence, ligand binding, subunit association, protein 
conformational changes, and protein denaturation.  Fluorophores have short lifetimes of 
between 0.5-100 ns however, this short lifetime is sufficient for the excited fluorophore 
to interact with external molecules that will cause the excited product to release some 
energy in a nonradiative pathway thus lowering the fluorescence quantum yield (54).  
This lowering of the quantum yield is known as fluorescence quenching.  Tryptophan 
fluorescence is known to be quenched by iodide, oxygen and nucleotides, to name a few 
(55). 
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Hfq does not have any native Trp residues.  This lack of Trp allows for Trp 
residues to be placed in strategic locations throughout the protein.  These locations are 
chosen based on germane structures of Hfq bound to RNA.  Using a single Trp point 
mutant it is then possible to observe the fluorescence of Trp, know where that 
fluorescence is located within the protein and potentially observe fluorescence 
quenching by RNA if the RNA sequence interacts with the protein where the Trp 
residue is located.  This technique is known as Trp fluorescence quenching (TFQ). 
2.2 Experimental Procedures 
Hfq plasmid constructs and site directed mutagenesis – WT E. coli hfq full length and 
truncated (residues 2-69) and WT S. aureus hfq full length DNA sequences were 
provided by Dr. Jill Orans in Dr. Brennan’s lab in the pTYB11 expression vector.  WT L. 
monocytogenes hfq DNA was ordered from Genscript USA, Inc. (Picastaway, NJ) in the 
pTYB11 expression vector.  All Trp mutants in E. coli, S. aureus, and L. monocytogenes 
were created using site-directed mutagenesis following the Stratagene site-directed 
mutagenesis protocol. In brief, this protocol uses primers that contain the mutation 
desired to PCR amplify DNA, which is then transformed into DH5α cells and plated 
onto Luria broth (LB) agar selective plates (for the pTYB11 vector these are plates 
containing 50 µg/mL ampicillin).  Colonies are then grown overnight in liquid LB 
containing 50 µg/mL ampicillin and then miniprepped to purify the DNA vector.  The 
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resulting purified DNA vector is then sequenced (Eton Bioscience, Inc., San Diego, CA) 
to confirm incorporation of the desired mutation.   
Protein Overexpression and Purification – All Hfq homologues and the Trp mutants 
were transformed into the expression strain ER2566 Δhfq.  This strain has the native E. 
coli Hfq deleted so that only the desired Hfq will be purified.  To express the protein a 
9L LB growth was performed using 50 µg/mL ampicillin for selection.  The cells were 
grown at 37 oC with shaking at 200 rpm until they reached an OD600 between 0.4 and 0.6.  
Protein expression was then induced using 0.5 mM Isopropyl β-D-1-
thiogalactopyranoside (IPTG).  Once expression was induced the cells were grown for 20 
hours at 18 oC with shaking at 200 rpm. Cells were then harvested by centrifugation at 
4,000 rpm for 10 minutes (min.) at 4 oC and either stored at -80 oC or lysed immediately.  
Cell pellets were resuspended in 30 mL lysis buffer (20 mM HEPES pH 8.0, 500 mM 
NaCl, 0.5 mM EDTA, 1 mM phenylmethanesulfonylfluoride (PMSF), 10 µg/mL DNase, 
10 µg/mL RNase). To ensure contaminating RNA and DNA does not come along during 
purification the crude lysate was stirred at 4 oC for 2 hours before clarification at 17,500 
rpm for 30 min at 4 oC.  Hfq was then purified from clarified lysate on a chitin column 
using the IMPACT-CN system as described (33).  WT E. coli and S. aureus Hfq and their 
Trp mutants were buffer exchanged into 20 mM HEPES pH 8.0, 150 mM NaCl, 0.5 mM 
EDTA and concentrated to 100 µM-200 µM hexamer.  WT E. coli and S. aureus Hfq was 
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stored at 4 oC while their Trp mutants were stored at 25 oC due to cold denaturation.  
WT L. monocytogenes and its Trp mutants were concentrated in 20 mM HEPES pH 8.0, 
500 mM NaCl, 0.5 mM EDTA to 100 µM hexamer and stored at 25 0C due to cold 
denaturation. 
Crystallization, Data collection, Structure determination and Refinement – All E. coli Hfq Trp 
mutants used for crystallization were C-terminally truncated at residue 69.  Hfq Trp 
mutant crystals were obtained by hanging-drop vapor diffusion method.  Drops 
contained 1 µL protein to 1 µL well solution with a range of protein concentrations (5, 7 
and 9 mg/mL).  Protein was crystallized from solutions containing 22-28% PEG 3350, 26-
32% Isopropanol and 0.1 M Tris pH 8.0-9.0.  Crystals were flash frozen in a nitrogen 
stream at 100 K.  X-ray data were collected under cryo-conditions at the Advanced 
Photon Source (Beamline 22-ID or BM) in Argonne, IL.  Data were reduced using HKL-
2000 or HKL-3000 (56).  Structure determination via molecular replacement was carried 
out in Phaser (57) using PDB ID: 1HK9 as a search model.  Structure building and 
refinement were carried out in Coot (58) and Phenix (59), respectively.  Selected data 
reduction and refinement statistics are shown in Table 1.  Root Mean Square Deviation 
(RMSD) calculations were done using secondary structure matching and Cα alignment 
via SSM superpose (47). 
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Table 1: Selected Crystallographic Data 
 Hfq F11W Hfq Y25W Hfq F39W Hfq F42W 
Space Group P21212 P21 P213 R3 
Cell Dimension 
a,b,c 
α,β,γ 
34.1, 66.3, 84.1 
90.0, 90.0, 90.0 
31.6, 89.1, 67.0 
90, 89.99, 90.0 
90.1, 90.1, 90.1 
90.0, 90.0, 90.0 
104.0, 104.0, 28.2 
90.0, 90.0, 120.0 
Resolution, Å 50-1.93 50-2.20 50-1.83 50-1.79 
I/σa 19.53 (6.01)a 51.2 (17.1) 23.42 (2.29) 64.75 (8.49) 
Rsym, %a 6.8 (29.4) 4.1 (8.1) 6.0 (52.4) 5.9 (33.8) 
# of reflections 55490 87814 91542 120088 
# of unique reflections 15374 18472 21729 10698 
Completeness, %a 98.2 (90.1) 96.8 (82.5) 99.6 (98.6) 100.0 (100.0) 
Refinement 
Rwork/Rfree (%)b 17.7/21.6 21.3/27.6 20.5/25.7 18.0/23.0 
Atoms (#) 
Protein 1623 3059 2145 1048 
Solvent 192 61 128 89 
Average B Factor (Å2) 28.1 44.5 11.4 34.0 
Root-mean-square-deviations 
Bond lengths (Å) 0.007 0.008 0.008 0.005 
Bond Angles (o) 1.213 1.110 1.207 1.031 
Ramachandran Analysis 
Most favored (%) 95.0 94.6 95.49 96.1 
Add Favored (%) 4.0 4.9 2.63 3.9 
Disfavored (%) 1.0 0.5 1.88 0.0 
 
Fluorescence Polarization – Fluorescence polarization measurements were 
performed with a PanVera Beacon 2000 instrument (Invitrogen, Madison, WI, USA) at 
295 K.  Hfq was serially diluted into 100 µL of binding buffer containing 20 mM HEPES 
pH 8.0, 0.5 mM EDTA, 200 mM NaCl and 1 nM fluorescein-labeled RNA.  Samples were 
excited at 490 nm and emission was detected at 530 nm.  Data were analyzed using 
Kaleidograph assuming a 1:1 stoichiometry between one Hfq hexamer and one molecule 
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of RNA.  The data were plotted using KaleidoGraph (Synergy Software) and the 
generated curves were fit using non-linear least squared analysis, assuming a 
bimolecular model such that the Kd values represent the protein concentration at half 
maximal RNA binding (60). The binding isotherms were fit to the equation, P = [(Pbound-
Pfree) [protein]/(Kd+[protein])]+Pfree, with Pbound being the maximum polarization at 
saturation, P is the polarization at a given protein concentration, Pfree is the polarization 
of free fluorescein-labeled RNA and Kd is the equilibrium dissociation constant. All 
values were independently determined in triplicate. 
Tryptophan Fluorescence Quenching (TFQ) – Fluorescence quenching 
measurements were performed using an RF-5301PC spectrofluorophotometer 
(Shimadzu, Nakagyo-ku, Kyoto, Japan) at 298 K.  Fluorescence quenching was done by 
exciting Trp at 298 nm and scanning the emission fluorescence from 320-400 nm.  A 1 
mL sample containing 1 µM of each Hfq protein in binding buffer (20 mM HEPES pH 
8.0, 150 mM or 200 mM NaCl, 0.5 mM EDTA) was scanned and then a titration was done 
using a specific RNA sequence.  Two concentration ranges were examined; initially 10 – 
40 µM RNA to determine the overall sensitivity of the system and then 1 - 4 µM RNA in 
an attempt to decrease ambiguity that might result from secondary, lower affinity 
binding.  Each titration was done in triplicate.  Data were analyzed using Microsoft 
Excel.  Quenching was determined using the arbitrary fluorescence maximal height for 
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each Trp mutant.  Quenching percentage was calculated using the following equation: (1 
– ((FR-FB) ÷ (F0-FB))) x 100, where FR is the fluorescence value after addition of RNA to the 
Hfq solution, F0 is the initial fluorescence value of the Hfq solution without RNA and FB 
is the fluorescence of buffer without RNA or Hfq.  All data were adjusted to exclude 
buffer effects. 
RNA samples and generation of the 5'-UTR of hfq mRNA – Oligoribonucleotides 
were purchased from IDT (Coralville, IA) or Oligos etc (Wilsonville, OR) and used 
without further purification.  The 64 nucleotide 5'-UTR of the hfq mRNA of E. coli was 
synthesized biochemically.  Briefly, the pMCSG7 vector was modified to include the 
DNA sequence 5' - TAA TAC GAC TCA CTA TAG GAT TTT TTC AGA ATC GAA 
AGG TTC AAA GTA CAA ATA AGC ATA TAA GGA AAA GAG AGA ATG GGA TCC 
– 3' using standard ligation independent cloning (LIC) techniques.  To prepare RNA, the 
modified vector was midiprepped, phenol:chloroform extracted, and 8 to 20 µg of clean 
DNA vector was digested using BamH1-HF (NEB, Ipswich, MA) at 37 oC for 16 hours.  
The T7 RNA polymerase reaction (100 µL 10X Buffer (0.5 M Tris pH 7.5, 0.25 M MgCl2, 
0.05 M EDTA), 40 µL 50 mM spermidine, 200 µL rNTP mix (20 mM/rNTP), 30 µL 100 
units/mL inorganic pyrophosphatase (NEB), 80 µL 1 mg/mL T7 RNA polymerase, 60 µL 
8-20 µg/mL digested DNA vector, 440 µL dH2O) was carried out at 37 oC for 16 hours 
and quenched with 2 mL 0.45 M EDTA.  The reaction was then purified by acidic 
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phenol:chloroform extraction and ethanol precipitated at -80 oC for 16 hours.  RNA was 
centrifuged at 13,000 rpm for 30 min. at 4 oC. The RNA pellet was further purified using 
70% ethanol, centrifuged at 13,000 rpm for 30 min. at 4 oC and air dried before 
resuspending in 100 µL 10 mM sodium cacodylate pH 6.5. 
 
2.3 Tryptophan Fluorescence Can Correctly Identify Known 
Binding Faces 
2.3.1 Escherichia Coli Hfq 
2.3.1.1 Development of TFQ Assay 
Initially four Trp mutants were created in E. coli Hfq to verify that a TFQ method 
is robust and can correctly identify known binding interactions.  E. coli Hfq residue Y25, 
which stacks with the R-site bound adenine ring of the Hfq-A15 and A7-Hfq-AU6A 
structures on the distal face, was mutated to Trp (Y25W) (42, 44). Similarly, the E. coli 
Hfq-AU6A RNA structure showed base stacking between residue F42 and uridine, hence 
the F42W mutant was used to examine proximal face binding (41).  We also mutated 
residue F39 (F39W) as a proximal face “edge” binding site, based on its recently reported 
importance in binding the sRNAs ArcZ and McaS (61). To explore potential binding to 
the positively charged cleft on the surface of E. coli Hfq we chose to mutate F11 (F11W).   
All mutations were generated using both the full length WT E. coli Hfq and the E. coli 
Hfq C-terminal truncation protein, which contains residues 2-69.  
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Initially the four truncated mutants were purified and prepared for TFQ.  Each 
mutant was used at 1 µM in a buffer containing 150 mM NaCl.  An initial fluorescence 
scan was taken by exciting Trp at 298 nm and scanning Trp emission from 320-400 nm.  
Then the desired RNA substrate was titrated into the sample in 10 µM increments until a 
 
Figure 12: Tryptophan Fluorescence Quenching Example 
This graph illustrates the raw data from a Trp quenching experiment when 
quenching occurs.  To determine the percentage of quenching the equation (1 – 
((FR-FB) ÷ (F0-FB))) x 100 is used.  FR is the fluorescence value after addition of 
RNA to the Hfq solution, F0 is the initial fluorescence value of the Hfq solution 
without RNA and FB is the fluorescence of buffer without RNA or Hfq 
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final concentration of 40 µM was reached (Figure 12).  To determine the percentage of 
quenching the simple equation (1 – ((FR-FB) ÷ (F0-FB))) x 100 is used.  FR is the 
fluorescence value after addition of RNA to the Hfq solution, F0 is the initial fluorescence 
value of the Hfq solution without RNA and FB is the fluorescence of buffer without RNA 
or Hfq (Figure 12). Each mutant is tested for quenching in triplicate and the quenching 
results for all mutants are plotted as a bar chart. We define a significant Hfq-RNA 
interaction when the final titration has quenching that exceeds 10% and is 2-fold greater 
than the initial titration quench.  If both faces meet these criteria then we conclude the 
RNA substrate is able to bind both faces. If one face is quenched at least 1.5-fold greater 
than the other, then that face is defined as being the preferential binding face.   
The control RNA sequences used were A15 and U6, which bind to the distal and 
proximal faces, respectively. The results from these initial experiments indicated that 
some non-specific binding interactions were being detected as the RNA sequence A15 
was observed to quench both faces, with a preference for binding to the distal face, along 
with showing some stability issues for both the F11W and F39W mutants (Figure 13).  
Specifically the F11W and F39W mutants were observed to precipitate out of solution.  
This precipitation then would cause an artificial increase in fluorescence due to non-
specific light scattering. 
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Figure 13: Initial TFQ Experiments Using Hfq Truncated Mutants 
Initial control experiments using four point mutants, 1 = F11W, 3 = Y25W, 6 = 
F39W, and 7 = F42W made in the truncated (residues 2-69) E. coli Hfq.  These 
graphs show either non-specific interactions or lower affinity interactions at 
these RNA concentrations. 
 
To determine if the missing C-terminal residues were involved in the RNA 
interactions the full length F11W, Y25W, F39W and F42W mutants were created and 
next used for TFQ experiments titrating RNA from 10 - 40 µM (Figure 14).  This 
experiment indicated that the full length E. coli Hfq is more stable in the presence of 
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RNA as F11W and F39W no longer precipitate, however it did not improve the 
observation of lower affinity binding interactions for A15 to the proximal face. 
 
Figure 14: Initial TFQ Experiments Using Hfq Full Length Mutants 
Control TFQ experiments using the point mutants 1 = F11W, 3 = Y25W, 6 = F39W 
and 7 = F42W that were created in full length E. coli Hfq.  Including the C-
terminal tail aided in preventing precipitation however; it did not reduce the 
observed lower affinity binding of A15 for the proximal face. 
 
To control non-specific interactions the salt concentration can be raised.  
Therefore to reduce nonspecific interactions the NaCl concentration in the binding 
buffer was increased from 150 mM to 200 mM and the TFQ experiment was repeated 
 37 
 
using the truncated E. coli Hfq mutants (Figure 15).  Raising the salt concentration 
improved stability of the proteins and significantly reduced the observed lower affinity 
interactions thus indicating that higher salt concentration should be used.  However, the 
lower affinity binding of A15 to the proximal face is still detected. 
 
Figure 15: TFQ with 200 mM NaCl and the E. coli Hfq Truncated Mutants 
Control TFQ experiments using the truncated point mutants 1 = F11W, 3 = Y25W, 
6 = F39W and 7 = F42W of E. coli Hfq.  The sodium chloride concentration present 
in the binding buffer was raised from 150 mM to 200 mM to reduce nonspecific 
interactions.  Raising salt concentration reduced nonspecific interactions 
indicating that higher salt concentrations should be used for all TFQ 
experiments. 
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Finally, as another step in eliminating lower affinity binding and thus quenching 
of less preferred sites, the RNA concentration was lowered by 10-fold and a range of 1-4 
µM was used to see if the lower affinity interactions could be further reduced using a 
 
Figure 16: TFQ using 10-fold less RNA with Full Length Hfq Mutants 
 
Control TFQ experiments using the Trp point mutants 1 = F11W, 3 = Y25W, 6 = 
F39W and 7 = F42W that were made in the truncated (residues 2-69) E. coli Hfq.  
The RNA concentration range was reduced 10-fold to bring the ratio of 
protein:RNA into a more appropriate range (1:1 – 1:4).  Reducing the amount of 
RNA titrated into the protein sample dramatically reduced the observed lower 
affinity interactions while not significantly impacting expected binding. 
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concentration range that put the Hfq hexamer:RNA ratio into the 1-4 range versus the 
10-40 range (Figure 16).  This drop in the RNA concentration did reduce the lower 
affinity interactions and at the same time did not significantly impact the quenching of 
those residues that are expected to interact.  Thus the design for the TFQ experiment 
was finalized to use the full length Hfq sequence, 200 mM NaCl in the binding buffer 
and a range of 1 to 4 µM RNA. 
2.3.1.2 TFQ controls for E. coli Hfq 
It was observed that the distal face mutation, Y25W worsened A15 binding by 
180-fold (see section 2.4).  While this significant drop in binding did not prevent binding 
of A15 it is clear that weaker binding RNA substrates may not bind to the Y25W mutant 
and no quenching would be observed hence resulting in a mixed binding site or 
incorrect identification of the binding site.  Therefore two other distal face Trp mutants 
were designed based on the E. coli Hfq-A15 and A7-Hfq-AU6A structures, K31W and 
Q33W.  K31 is about 6 Å from bound RNA on the distal face of E. coli Hfq and does not 
appear to interact, thus creating a negative control for recognizing the distal face binding 
motif while Q33 interacts with A15 through its backbone carbonyl and amide groups.  
Modeling Trp in the Q33 position suggests that the Trp side chain may be able to base 
stack with the bound adenosine or at least approach the adenine ring closely (Figure 17).  
Another mutation, R17W, was made at this point to study a recently proposed lateral  
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Figure 17: Modeling of Trp into Residues Q33 and K31 
Residues Q33 and K31 were modeled as Trp point mutants to analyze the 
likelihood that the identified target amino acid would base stack with bound 
ribonucleotide.  It is shown that Q33W is capable of base stacking with the bound 
adenosine while K31W does not thus suggesting that Q33W will experience 
quenching in the presence of adenosine while K31W will not.  Modeling was 
performed using Pymol (48). 
 
Figure 18: SAXS Envelope of Full Length E. coli Hfq Illustrating Location of C-
terminal Mutants 
A SAXS envelope of full length WT E. coli Hfq.  The crystal structure of a 
truncated (residues 2-69) WT E. coli Hfq is fit into the envelope to illustrate where 
the C-terminal tail residues are expected to be.  The red boxes indicate the 
speculative location of the mutated residues.  
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binding site identified for RhyB RNA binding to St Hfq (52).  Finally, to further explore 
the role that the C-terminal residues may play in RNA binding for E. coli Hfq, three 
mutations were designed throughout the length of the tail; G77W, Y83W and Q95W 
(Figure 18). 
 
Figure 19: Final E. coli Hfq TFQ A15 and U6 Graphs 
Control TFQ experiments using the point mutants 1 = F11W, 2 = R17W, 3 = 
Y25W, 4 = K31W, 5 = Q33W, 6 = F39W, 7 = F42W, 8 = G77W, 9 = Y83W, 10 = 
Q95W that were made in the full length E. coli Hfq.  The sequences A15 and U6, 
which bind the distal and proximal faces respectively, were titrated from 1 to 4 
µM.  As these graphs illustrate, both sequences were observed to bind to the 
expected face. 
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With all of these mutants in hand the designed TFQ experiment was performed 
in triplicate using the control sequences A15 and U6 (Figure 19).  It was observed that 
TFQ correctly identifies the binding face for a particular RNA.  Specifically on the distal 
face the Y25W and Q33W mutants are significantly quenched at all A15 RNA 
concentrations while the K31W mutant is not quenched as would be expected if the 
binding mode has not been disturbed.  There is some quenching observed for both F11W 
and G77W indicating that these residues may interact with longer A-tract RNA.  Also for 
A15 the proximal face mutants, F42W and F39W, are not quenched in the 1-4 µM RNA 
range although they are quenched in the 10-40 µM range, indicating some lower affinity 
binding of A15 at high RNA concentrations to the proximal face.  Residues R17W, K31W, 
Y83W and Q95W do not quench in the lower micromolar range indicating no interaction 
occurring between these residues and A15. 
U6 was also observed to bind as expected, i.e. to the pore of the proximal face, 
with significant quenching being observed for F42W at all RNA concentrations (Figure 
19).  F11W has an enhanced fluorescence signal upon U6 binding suggesting that the 
environment F11W experiences is being altered, most likely by some slight structural 
rearrangement.  Since the increase in fluorescence happens immediately upon RNA 
addition and then does not continue to increase this change is unlikely due to RNA 
binding. No other tested mutants quench in the lower concentration range (1 – 4 µM).  In 
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the 10-40 µM RNA range, residue F39W shows some quenching, although this is not as 
significant as that observed for residue F42W, but suggests a second, weaker affinity 
binding site.  These results demonstrate that Trp residues show fluorescence quenching 
when the appropriate RNA sequence is bound in their proximity. The change in 
fluorescence for residue F11W is intriguing as it is quenched by A15 and enhanced by U6.  
To ensure that the observed quenching is not simply an effect of nonspecific 
quenching by RNA nucleotides, N-acetyl-L-tryptophanamide (NAT) was used to mimic 
a Trp residue (Figure 20).  A15 or U6 was titrated into a 1 or 6 µM NAT sample (Figure 
21).  Neither RNA sequence induced quenching indicating that a specific or proximal 
interaction must occur to observe TFQ.  Since significant quenching is only observed 
 
Figure 20: Structure of N-acetyl-L-tryptophanamide 
The chemical structure of N-acetyl-L-tryptophanamide (NAT) mimics the 
structure Trp takes when it is connected to other amino acids to form a protein. 
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Figure 21: N-Acetyl-L-Tryptophanamide Quenching by A15 and U6 
TFQ experiments using NAT.  A15 and U6 were titrated into a 1 or 6 µM sample of 
NAT and examined for TFQ.  The graphs illustrate no quenching for either 
substrate indicating that specific interactions between Trp and a nucleotide must 
occur to observe quenching. 
for residues that are known from crystal structures to interact directly with RNA, we 
conclude that TFQ can be used to map accurately, albeit at lower resolution, specific  
RNA binding sites on Hfq.   
2.3.2 Staphylococcus aureus Hfq 
The main difference that exists between Gram-positive and Gram-negative 
homologues of Hfq resides in the distal face binding motif.  In Gram-negative Hfq 
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homologues, specifically E. coli, the distal face has an (A-R-N)n RNA binding motif. In 
Gram-positive Hfq the sequence differences lead to a loss of the A site, and equivalent 
but not identical R-sites with the base stacking mode modestly different.  In Gram-
negative Hfq the main base-stacking residue in the R-site is L32 while in Gram-positive 
Hfq the main R-site base stacking residue is Y25 (Figures 7 & 8).  Also in Gram-negative 
bacteria K31 does not interact with bound RNA while in Gram-positive bacteria Q31 
stacks with the adenine ring of the adenosine in the L-site.  This difference in the distal 
face binding mode should be possible to detect by TFQ since fluorescence quenching 
requires a direct interaction.   
The S. aureus Hfq-A4 structure indicates that residues F25 and Q31 stack with the 
R-site and L-site, respectively, and therefore they were mutated to F25W and Q31W for 
use in our TFQ assay (62).  Analysis of the S. aureus Hfq-AU5G structure indicates that 
residue Y42 should be mutated (Y42W) to probe proximal face interaction (38).  Due to 
an inability to make S. aureus Y42W a second Gram-positive Hfq homologue from L. 
monocytogenes was used.  Alignment of these two homologues reveals a 40% sequence 
identity and 81% sequence similarity.  It also reveals that L. monocytogenes Hfq residue 
Y43 is equivalent to S. aureus residue Y42 (Figure 22).  Thus L. monocytogenes Hfq F43W 
was used to probe proximal face binding by selected RNA sequences. The S. aureus 
Y25W, Q31W, and L. monocytogenes Y43W mutations were made in full length S. aureus 
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and L. monocytogenes Hfq, which are both 25 residues shorter than E. coli Hfq. 
 
Figure 22: Sequence Alignment of S. aureus and L. monocytogenes Hfq Homologues 
Sequence alignment was generated in CLC Sequence Viewer (CLC Bio, 
Cambridge, MA). The bottom row indicates those residues that are conserved 
between the two Hfq homologues.  The red square highlights S. aureus Hfq 
residue Y42 and the corresponding residue Y43 in L. monocytogenes Hfq. 
 
These mutants were then used in TFQ experiments with the control RNA 
sequences, A15 and U6.  These results indicate that it is indeed possible to properly 
identify the RNA binding surface by TFQ as both S. aureus Y25W and Q31W are 
significantly quenched in the presence of A15 and not by U6 while L. monocytogenes Y43W 
is significantly quenched in the presence of U6 and not A15 (Figure 23).  These results also 
show that it is possible to use TFQ to discern the differences between the different distal 
face binding motifs for Gram-negative versus Gram-positive Hfq homologues.  This is 
shown by the simple fact that TFQ detects significant quenching for S. aureus Q31W, 
which base stacks with RNA in the germane crystal structures, while TFQ detects no 
quenching for E. coli K31W, which is known to be physically close, ~ 6 Å, but not to 
interact with RNA in the germane crystal structures (Figures 19 & 23).  This observation 
illustrates the strength of TFQ and supports the conclusion that these designed Trp 
mutants do not alter the known RNA binding motifs. 
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Figure 23: TFQ of Gram-positive Hfq homologues using A15 and U6 
Control TFQ experiments using the point mutants 1 = S. aureus F25W, 2 = S. 
aureus Q31W and 3 = L. monocytogenes F43W that were made in the full length S. 
aureus and L. monocytogenes Hfq homologues.  The sequences A15 and U6 were 
titrated from 1 to 4 µM.  As these graphs illustrate, both sequences were observed 
to bind to the correct face. 
 
2.4  The tryptophan mutants can reduce binding affinity but do 
not create false binding sites 
Fluorescence Polarization (FP) is a technique that uses polarized light to excite a 
fluorophore which will then emit polarized light.  If the fluorescent molecule is capable 
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of moving freely before emitting light then the polarization will be reduced (63).  The 
ability of a molecule to tumble freely in solution is dependent on its size and mass, a 
larger or less compact macromolecule will move more slowly than a small 
macromolecule (60).  Thus it is possible to measure the fluorescence polarization of a 
small substrate, titrate in a binding partner that is a larger size and observe the increase 
in polarization that happens.  Polarization is defined by the equation: P = (I‖-I⊥)/( I‖+I⊥) 
where P is polarization, I∥ and I⊥ are the intensities of the emission viewed through parallel 
and perpendicularly arranged polarizers, respectively.  By titrating in a macromolecule of 
interest until polarization has stopped increasing a binding constant can be determined.  To 
determine the binding constant of Hfq to target RNA sequences the RNA substrate is labeled 
with the 5-carboxyfluorescein (5-FAM) fluorophore and the polarization of RNA is 
monitored as Hfq is titrated until polarization stops increasing.  The ensuing graph is then 
fit using the equation discussed in section 2.2. 
To ensure that the designed Trp mutants did not significantly impact the 
function of Hfq, FP-based RNA binding assays were used to determine the equilibrium 
dissociation constants (Kd) of each mutant for the control RNA sequences A15 and U6. 
Calculated affinities and the fold difference from WT binding affinities are shown in 
Table 2.  
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Table 2: Dissociation Constants (Kd) for Trp Mutants to rA15 and rU6 
A15 U6 
E. coli Hfq 
WT Hfq S 1.4 nM ± 0.9a  766.0 nM ± 73.7  
F11W 7.1 nM ± 0.6 5.0 502.7 nM ± 55.5 0.7 
R17W 3.7 nM ± 1.5 2.6 1.6 µM ± 0.08 2.1 
Y25W 258.2 nM ± 32.7 184.4 836.8 nM ± 62.5 1.1 
K31W 1.4 nM ± 0.5 1.0 1123.3 ± 73.0 1.5 
Q33W 15.9 nM ± 3.6 11.4 404.7 nM ± 182.4 0.5 
F39W 0.59 nM ± 0.35 0.4 2.0 µM ± 0.4  2.6 
F42W 0.28 nM ± 0.09 0.2 4.8 µM ± 782.5 6.2 
 
G77W 2.9 nM ± 1.7 2.1 379.9 nM ± 93.2 0.5 
Y83W 7.4 nM ± 2.8 5.3 777.9 nM ± 254.1 1.0 
Q95W 2.6 nM ± 1.1 1.9 848.3 nM ± 289.4 1.1 
S. aureus Hfq 
WT Hfq 4.2 nM ± 0.5b  69.8 nM ± 7.0b  
F25W 11.3 µM ± 5.0 2700 41.9 nM ± 25.1 0.6 
Q31W 1.6 µM ± 0.08 386.7 114 nM ± 23.2 1.6 
a value taken from (44) b values taken from (46) Red highlights those residues that are 
displaying significant changes in Kd. 
 
It was observed that mutating residue E. coli Y25W reduces the binding affinity 
of A15 184-fold (from 1.4 nM to 258.2 nM) and mutating residue E. coli Q33W reduces the 
binding affinity of A15 12-fold (from 1.4 nM to 15.9 nM) (Table 2).  Mutating S. aureus  
F25W reduces A15 binding by 2,690-fold (from 4.2 nM to 11.3 µM) and mutating S. aureus 
Q31W reduces A15 binding by 381-fold (from 4.2 nM to 1.6 µM) (Table 2). The other 
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mutations do not adversely affect A15 binding.  It was also observed that the E. coli F42W 
mutation reduces U6 binding affinity 6-fold (766.0 nM to 4.8 µM), whilst the other 
residues show no adverse effects.  We conclude that mutations involved in RNA binding 
show a decrease in binding affinity to the RNA sequences they bind.  However, since the 
protein-RNA interaction is still observed via TFQ and florescence polarization it is 
concluded that this reduction in binding affinity is not detrimental to the ability of TFQ 
to detect which face a particular RNA sequence binds.  It is noted that there is the chance 
for false negatives to occur, which indicates the importance of screening around the 
identified Hfq binding sites for the Trp mutants that least affect binding affinity while 
still detecting binding by TFQ.  Additionally, it was also noted that mutations proximal 
to a particular binding site do not affect the affinity of distant sites for their preferred 
RNA sequence. For example, the E. coli F39W protein binds A15 with a Kd = 0.6 nM and 
the E. coli Y25W protein binds U6 with a Kd = 836 nM, the same values as observed for 
wild type Hfq binding to these oligoribonucleotides. 
2.5 Crystal Structures of Trp Mutants Show Minor Structural 
Perturbation 
To verify that Trp mutations of E. coli Hfq do not significantly impact the overall 
global structure of the resulting Hfq protein, we determined the crystal structures of 
four key E. coli Trp mutants (F11W, Y25W, F39W, F42W) using the C-terminally 
truncated construct (residues 2-69) (PDB IDs: 4JRK, 4JUV, 4JRI, 4JLI, respectively).  
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These structures were then compared to the WT structure determined by Sauter et al (39) 
(PDB ID: 1HK9).  All Root Mean Square Deviation (RMSD) for protomer:protomer and 
hexamer:hexamer for each Trp mutant as compared to WT can be found in Table 3.  
Table 3: RMSD‘s of WT:Mutant E. coli Hfq Structures 
WT:Mutant RMSD 
 Monomer:Monomer Hexamer:Hexamer 
F11W 0.30 – 1.05 Å 
Å 
2.48 Å 
Y25W 0.27 – 0.64 Å 0.72 Å 
F39W 0.37 – 0.54 Å 1.00 Å 
F42W 0.31 – 0.52 Å 1.20 Å 
 
E. coli Hfq Y25W crystallized in space group P21 and diffracted to 2.20 Å 
resolution.  The superposition of Y25W and WT E. coli Hfq is shown in Figure 24A and 
indicates no structural changes.   Alignment of the Y25W mutant with WT E. coli Hfq-A15 
provides a rationale for the significant change we observe in the Kd of A15 for the mutant.  
The orientation of the Trp side chain is such that a shift in its conformation has to occur 
in order to avoid a clash with either the adenosine base or the 2' hydroxyl group of 
ribose (Figure 24B).  E. coli Hfq F42W crystallized in the rhombohedral space group R3 
and diffracted to 1.79 Å resolution.   Superposition of F42W and WT E. coli Hfq is shown 
in Figure 24A and indicates no structural changes.  This alignment also indicates that 
there would be little change in the binding and recognition of uridine, supporting the 
slightly lower binding affinity.  The F39W mutant crystallized in the cubic space group  
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Figure 24: Overlay of Trp Mutant Structures to WT E. coli Structure 
(A) Overlay of the hexamer structures of WT E. coli Hfq and the selected 
mutants: F11W, Y25W, F39W, and F42W.  All proteins are shown as cartoons 
with WT E. coli Hfq colored cyan, Y25W colored green, F11W colored red, F39W 
colored yellow, and F42W colored blue.  The calculated RMSDs reveal that each 
mutation does not affect the protomeric structures.  (B) Two close up views of 
the overlay of the structures of the WT E. coli Hfq bound to A15 and the Y25W 
mutation near the position of the substitution and R-site.  Here it can be seen that 
W25 takes two conformations with one monomer having both conformations 
present.  One confirmation occurs in 2 out of 6 protomers (left) and would block 
adenine insertion into the R-site.  The second conformation (right) occurs in 5 out 
of 6 protomers and allows stacking with adenine.  However the 2' ribose oxygen 
clashes with the indole ring, requiring some phosphodiester or polypeptide 
backbone adjustment to relieve the clash.  These two observations are likely the 
cause for the significant reduction in A15 binding to the distal face mutant. (C) 
Close up of the overlay of the apo WT E. coli Hfq and F11W hexamers about β2 
and β5.  Highlighted by red boxes are the two major conformational differences 
between the F11W protein and WT E. coli Hfq. 
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P213 and diffracted to 1.86 Å resolution. Superposition of F39W and WT E. coli Hfq is 
shown in Figure 24A and indicates reasonable structural identity.  The F11W mutant 
crystallized in the orthorhombic space group P21212 and diffracted to 1.93 Å resolution.  
When individual subunits are aligned with those of WT E. coli Hfq the RMSD is 0.30-1.05 
Å.  Interestingly, alignment of the F11W hexamer and the WT E. coli Hfq hexamer results 
in an RMSD of 2.48 Å indicating a significant quaternary change (Figure 24A).  The 
structure of F11W provides the reason for this significant difference, although it cannot 
be ruled out that these structural changes may be due to crystal packing effects.  
Substitution of a Trp residue at position 11 causes a significant shortening of two β 
strands by the adjustment of the backbone about residues Q35 to F39 in β strand β2 
(Figure 24C) and residues I59 to V62 in the β strand β5 (Figure 24C).  These strands form 
part of the distal-side intersubunit interface, which is now partially disturbed.  Some 
change might have been expected from modeling studies given the bulkier nature of Trp 
but underscores the importance of having the high-resolution structure of this particular 
mutant.  Regardless, it is likely the remodeling of the β2 and β5 strands and their 
interaction with adjacent subunits are the origin of the perturbed, but not titratable, 
F11W TFQ data. 
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2.6. Conclusions and Future Directions 
The majority of wild type Hfqs have no native Trp.  This makes it straight 
forward to design Trp mutants, based on known structures and sequence alignments, 
and to use those trp mutants in order to map Hfq-RNA binding sites using TFQ.  TFQ 
will only be observed if a direct interaction occurs between the Trp residue and RNA as 
was shown by using NAT in control TFQ experiments (Figure 21).  Several different 
point mutants were created in the full length E. coli, S. aureus, and L. monocytogenes Hfq 
proteins.  These mutants were designed to cover the distal and proximal binding faces, a 
proposed lateral binding site in E. coli Hfq and the relatively long C-terminus in E. coli 
Hfq in order to explore if and how different RNA sequences may interact with these 
surfaces.  Using the control sequences A15 and U6, which bind the distal and proximal 
faces respectively; these mutants were examined for quenching.  Here it was shown that 
the TFQ experiment correctly identified where a particular RNA sequence will bind.  It 
was also observed that the TFQ experiments can differentiate between the two different 
known distal face binding motifs for Gram-negative (E. coli) and Gram-positive (S. 
aureus and L. monocytogenes) as we detected that residue 31 does not experience 
quenching for the E. coli Hfq while it sees significant quenching for S. aureus Hfq when 
A15 is titrated in.  The germane crystal structures show that residue 31 does not interact 
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with RNA in the E. coli-A15 structure while it is directly contacted by RNA in the S. 
aureus Hfq-A4 structure (Figure 25).  
To ensure that the Trp mutations did not destroy function, binding affinities for 
all Trp mutants to the control sequences were calculated (Table 2).  It was observed that 
those mutants responsible for binding do experience a change in binding that could 
result in lost binding for some weakly interacting RNA ligands.  Overall however the  
 
Figure 25: Comparison of the locations of residue 31 in the E. coli Hfq – A15 and S. 
aureus Hfq – A4 structures 
Residues E. coli K31 and S. aureus Q31 were modeled as Trp point mutants to 
analyze the differences in how these residues might interact with the bound 
ribonucleotide.  It is shown that E. coli K31W cannot stack with the bound 
adenosine while S. aureus Q31W can stack the bound adenosine thus suggesting 
that S. aureus Q31W will quench in the presence of adenosine and E. coli K31W 
will not. This is in agreement with the observations from TFQ experiments.  
These models were generated in Pymol using PDB IDs: 3GIB (E. coli Hfq-A15) (44) 
and 3QSU (S. aureus Hfq-A4) (46). 
vast majority of mutants do not impact function and RNA binding is observed for all 
mutants to all proper sequences.  To further verify that these mutants have not 
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disrupted Hfq function the structures of selected mutants were determined and, with 
the exception of F11W, only slight variations in the hexameric structures were seen.  
Taken together all of this data indicates that TFQ correctly identifies the face that a 
particular RNA sequence will bind to on Hfq in a simple, rapid manner. 
Future plans include expanding the mutants available for analyzing RNA 
binding to the S. aureus and L. monocytogenes Hfq homologues.  Further, it would be 
ideal to find a distal face mutant that will identify binding but not significantly impact 
RNA binding affinity.  Determining the apo crystal structures of all Trp mutants should 
be done to ensure that none of the mutants are significantly affecting the structure.  It is 
also of interest to determine the RNA bound crystal structure for those mutants that are 
involved in binding, for example determining the E. coli Q33W-A15 structure to see if the 
structure is changing upon binding.  Finally, as this thesis will expand upon in later 
chapters, it will be most interesting to use TFQ to study further the proposed distal face 
binding motifs and to analyze how physiologically relevant larger RNA sequences 
interact with Hfq. 
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3. The Hfq Distal Face Binding Motif 
3.1 Introduction to the Two Major Distal Face Binding Motifs  
The current structures for Hfq homologues bound to RNA sequences on the 
distal face exhibit two different binding motifs that are related to whether the Hfq 
homologue comes from a Gram-negative or Gram-positive bacterium (Figure 26).  In the 
Gram-negative structure of E. coli Hfq-A15 the observed binding on the distal face is an 
(A-R-N)n motif where A=adenine nucleotide, R=any purine nucleotide and N= any 
nucleotide (44).  This motif indicates that there are a maximum of 18 binding sites on the 
distal face of the hexamer.  
The A-site specificity of E. coli Hfq is conferred by peptide backbone amide and 
carbonyl oxygen hydrogen bonding between residue Q33 and the N7 and N6 atoms of 
adenine and a polar interaction between the Nε amide of residue Q52 and the adenine 
N1 atom (Figure 27).  The R-site of E. coli Hfq appears to be able to accommodate both 
adenosine and guanosine whereby the purine ring sticks into a pocket and packs against 
residues Y25, L26’, I30’ and L32’, where the prime indicates residues from the 
neighboring subunit.  The adenosine N3, N6, N1 and ribosyl 2' hydroxyl atoms 
Hydrogen bond to Nδ of residue N28, Oε atom of residue Q52, Oγ of residue T61, and 
the carbonyl oxygen of residue G29, respectively (Figure 27).  The N site has no protein-
nucleic acid interactions and likely represents the entrance or exit point for RNA.  
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Figure 26: Gram-positive and Gram-negative Distal Face Binding Motifs 
The RNA distal face binding motifs of Hfq in Gram-positive and Gram-negative 
bacteria. (A) View looking at the distal face of S. aureus Hfq (left, grey), B. subtilis 
Hfq (middle, blue), and E. coli Hfq (right, magenta).  Bound RNA is shown as a 
cartoon with the phosphate backbone colored yellow and the purine bases, 
shown as sticks, colored green.  A= adenine nucleotide only, R = any purine 
nucleotide, L = linker nucleotide, N = any nucleotide.  The 5’ and 3’ ends of the 
RNA strand are labeled. (B) Side view of the S. aureus Hfq-A4 (left, grey), B. 
subtilis Hfq-(AG)3A (middle, blue), and E. coli Hfq-A15 (right, magenta) 
complexes. Each Hfq is labeled as in A and the distal and proximal faces are 
labeled.  Taken from (46) 
 
 59 
 
 
Figure 27: E. coli Hfq A-site and R-site interactions 
The adenine nucleotide specificity (A-site) and purine nucleotide selectivity (R-
site) sites of E. coli Hfq.  In both figures Hfq is shown as a cartoon with the 
residues used for selectivity and adenosine shown as sticks.  Hfq is colored light 
green while the RNA is colored blue with the atoms for the side chains colored 
by atom type (carbon is green for Hfq and blue for RNA, oxygen is red, 
phosphorus is orange). Dotted lines represent Hydrogen bonds.  Images were 
made in Pymol using PDB ID: 3GIB (44). 
 
In the two structures of gram-positive Hfqs, S. aureus Hfq-(AA)3A and B. subtilis 
Hfq-(AG)3A, the observed binding motif has been shown to be an (R-L)n motif where 
R is any purine nucleotide and L is a linker nucleotide (Figure 26).  The R-site is located 
between β-strands 2 and 2’ from neighboring subunits.  The bound adenosine is found 
to base stack with residues F25, F26’ and F30’, where the prime indicates residues from 
the neighboring subunit, and make small van der Waals contacts with L27’ and M32’ 
(Figure 28). Hydrogen bonds for the R-site are observed between the side chain amide of 
N28’, the sugar O4’ and adenine N3 atoms and between the 2’-OH group and G29 
(Figure 28).  Finally there are hydrogen bonds between the N1 and exocyclic N6 amino 
group of the adenine and the hydroxyl groups of S61 and T62, respectively (Figure 28).   
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Figure 28: S. aureus Hfq R-site Interactions 
The purine selectivity site of S. aureus Hfq.  Hfq and RNA are shown as a cartoon 
with the selective residues and adenosine shown as sticks. Hfq is colored green 
while RNA is colored blue. The sticks are colored such that carbon is green for 
Hfq and blue for RNA, oxygen is red, nitrogen is blue, phosphorus is orange and 
sulfur is yellow. Image was made in Pymol using PDB ID: 3QSU (46). 
 
All of these interactions between RNA and the R-site of Hfq anchor the RNA to 
the distal face of Hfq.  For both distal face binding motifs the R-site is capable of 
accommodating a guanosine, although some movement must occur in the S. aureus Hfq-
A4 structure (Figure 29).  However, the currently available structures all have adenosine 
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bound in the R-site. Currently the only data that supports the proposed distal face (A-R-
N)n and (R-L)n motifs are RNA binding assays that determine binding affinity but do not 
confirm where the RNA sequence is actually binding on Hfq.  Thus since currently it is 
not known whether guanosine will actually bind in the R-site of the distal face motifs 
our TFQ method was applied to study how RNA sequences that fulfill these motifs 
interact with Hfq. 
 
Figure 29: E. coli and S. aureus Hfq with Modeled Guanosine in R-site 
The purine selectivity (R-site) sites for both E. coli and S. aureus Hfq with 
guanosine modeled into the site.  In both figures Hfq and RNA are shown as 
cartoons with the selective residues shown as sticks. Hfq is colored light green 
while the RNA is colored blue.  Adenosine is colored by atom such that carbon is 
light blue, oxygen is red, nitrogen is blue and phosphorus is orange. 
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3.2 E. coli Hfq Distal Face Binding is Restricted to (A-A-N)n 
Motifs 
To test the proposed (A-R-N)n distal face motif for E. coli Hfq two different RNA 
sequences were used, 5’ - AAGAAGAAGAAGAAG - 3’ (A-A-G)5 and 5’ - 
GGAGGAGGAGGAGGA - 3’ (G-G-A)5.  The (A-A-G)5 motif fulfills both the (A-R-N)n 
motif and an (A-A-N)n motif while the (G-G-A)5 sequence only fulfills the (A-R-N)n 
motif.  As expected the (A-A-G)5 sequence was observed to quench residues F11W and 
Q33W but not residues F39W or F42W indicating that (A-A-G)5 binds to the proximal 
face (Figure 30). Somewhat surprising was that (A-A-G)5 does not quench residue Y25W, 
which also lies on the distal face.  However, given that mutating Y25W causes a 180-fold 
 
Figure 30: E. coli Hfq TFQ with (A-A-G)5 RNA 
TFQ of E. coli Hfq Trp point mutants using the sequence (A-A-G)5.  1 = F11W, 2 = 
R17W, 3 = Y25W, 4 = K31W, 5 = Q33W, 6 = F39W, 7 = F42W, 8 = G77W, 9 = Y83W, 
10 = Q95W. Here it is observed that (A-A-G)5 quenches F11W and Q33W mutants 
indicating that (A-A-G)5 binds on the distal face of E. coli Hfq as expected. 
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reduction in binding affinity of A15, RNA sequences with weaker binding affinity, such 
as (A-A-G)5, are likely to be unable to bind well even at 4 µM and hence not bind nor 
quench this R-site substitution.  Regardless distal face binding is supported by the 
strong quenching of distal face residue Q33W (Figure 30). 
 In contrast to the observed distal face quenching for (A-A-G)5 when (G-G-A)5 is 
used for TFQ strong quenching is observed for residue F42W and not for Y25W or 
Q33W supporting proximal face binding only (Figure 31). (G-G-A)5 is also observed to 
quench residue Y83W in the C-terminal tail suggesting that longer RNA sequences that 
bind the proximal face may interact with the C-terminal tail, or that they bind the  
 
Figure 31: E. coli Hfq TFQ with (GGA)5 RNA 
TFQ of E. coli Hfq Trp point mutants using the sequence (G-G-A)5. 1 = F11W, 2 = 
R17W, 3 = Y25W, 4 = K31W, 5 = Q33W, 6 = F39W, 7 = F42W, 8 = G77W, 9 = Y83W, 
10 = Q95W.  It is observed that (G-G-A)5 quenches F42W and Y83W mutants 
indicating that (G-G-A)5 binds on the proximal face of E. coli Hfq and interacts 
with part of the C-terminal tail. 
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C-terminus independently but weakly.  Interestingly residues G77W, Y83W and Q95W 
are not quenched in the presence of (A-A-G)5 but residue G77W is quenched in the 
presence of (A-A-A)5 suggesting that these two distal face binding sequences may utilize 
different entrance/exit pathways or that an adenine but not guanosine is recognized by 
some residues near G77. 
From these data we can conclude that the E. coli Hfq distal face binding motif is a 
more restrictive (A-A-N)n motif rather than an (A-R-N)n motif and that the R-site is an 
adenosine only binding pocket. These results also demonstrate that some C-terminal 
residues are involved in the interaction with (A-A-A)n and (G-G-A)n tracts implying the 
C-terminal region of Hfq can interact with longer proximal face binding RNA.   
 
3.3 Proposed S. aureus Hfq Distal Face (R-L)n Motif is Restricted 
to an (A-L)n Motif 
To test the proposed (R-L)n binding motif of Gram-positive bacterial Hfq the 
sequences 5’ – AUAUAUA – 3’ (A-U)3A, 5’ – ACACACA – 3’ (A-C)3A, 5’ – GGGGGGG – 
3’ (G-G)3G and 5’ – GUGUGUG – 3’ (G-U)3G were tested by TFQ.  All of these sequences 
fulfill the proposed (R-L)n binding motif.  The (A-U)3A and (A-C)3A sequences also fulfill 
an (A-L)n motif while (G-G)3G and (G-U)3G sequences do not.  From our analysis of the 
S. aureus Hfq-A4 and B. subtilis Hfq-(A-G)3A complex structures the more restrictive (A-
L)n motif is suggested.  In these structures each one has an adenosine stacking in the R-
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site over residue F25W whilst the 3’ nucleotide, an A or G, is sitting directly over the L-
site forming residue Q31W. The TFQ results indicate that (A-U)3A and (A-C)3A 
sequences quench the distal face residues S. aureus Y25W and Q31W while (G-G)3G and 
(G-U)3G do not quench either of these residues (Figure 32).  (A-U)3A and (G-U)3G were 
observed to quench the proximal face residue L. monocytogenes F43W while (A-C)3A and 
(G-G)3G do not (Figure 32).  From these observations it can be concluded that the distal 
face binding motif for S. aureus Hfq, and likely most other Gram-positive bacterial Hfqs, 
is a more restrictive (A-L)n motif.  The fact that (A-U)3A quenches both faces is not a 
surprise as it has both adenosines and uridines and adenosine is capable of binding to 
either face, as seen in the S. aureus Hfq-AU5G structure (38) and the (A-U)3A sequence 
fulfills the distal face binding motif.  The observation that (G-U)3G binds to the proximal 
face of L. monocytogenes Hfq supports the hypothesis that the (A-U)3A sequence binds to 
the proximal face through the uridines and is not inhibited by the presence of adenosine 
or guanosine.  Finally the observation that (G-G)3G does not bind to either face is 
consistent with binding data that indicate that G7 does not bind to Hfq (38). To 
understand the binding mechanism of (G-U)3G high-resolution structural studies will 
need to be performed. 
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Figure 32: S. aureus Hfq TFQ Analysis of the Proposed (R-L)n binding motif 
TFQ of S. aureus Hfq Trp point mutants using the sequences (A-U)3A, (A-C)3A, 
(G-G)3G and (G-U)3G.  1 = S. aureus F25W, 2 = S. aureus Q31W and 3 = L. 
monocytogenes F43W.  It is observed that (A-U)3A and (A-C)3A quench the Y25W 
and Q31W mutants.  (A-U)3A and (G-U)3G are observed to quench the proximal 
pore F43W while (G-G)3G does not quench any residues. 
 
3.4 Conclusions and Future Directions 
Taken as a whole the data presented here illustrate that the proposed distal face 
binding motifs for both Gram-negative and Gram-positive bacterial homologues of Hfq 
can be redefined to a more restrictive sequence than previously hypothesized.  For E. 
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coli, and likely most other Gram-negative bacterial Hfqs, the distal face motif is restricted 
to an (A-A-N)n motif from the previously proposed (A-R-N)n motif.  For S. aureus and 
likely most other Gram-positive bacterial Hfqs the distal face motif is restricted to an (A-
L)n motif from the previously hypothesized (R-L)n motif.  To further verify that these 
proposed restricted binding motifs do indeed apply to other homologues of Hfq it is 
necessary to create the same mutants in at least one other homologue representing 
Gram-negative bacteria, such as Salmonella typhimurium (S. typhimurium), and one other 
homologue representing Gram-positive bacteria, such as L. monocytogenes.   
The ability to refine the distal face motifs further demonstrates the strength of 
TFQ for examining RNA binding to Hfq.  It has been previously hypothesized that the 
R-site was in reality an A-site due to the fact that all germane crystal structures have an 
adenosine bound in the R-site.  However, since in these structures it is feasible to model 
a guanosine in the R-site it was not logical to restrict the R-site to adenosine.  The distal 
face motifs have been extensively studied by binding assays and have illustrated that 
sequences which fulfill an (R-L)n motif do indeed bind to Hfq.  These techniques 
however do not provide any information on where a particular sequence is binding Hfq, 
they just indicate if a sequence binds.  TFQ is a simple, quick method for determining 
where a particular RNA sequence is binding.   
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The observation that the sequence (G-G-A)5 binds to the proximal face rather 
than the distal face of E. coli Hfq is intriguing.  The proximal face tends to bind uridine 
rich sequences and there is currently no high resolution structure of Hfq that has 
guanosine bound on the proximal face of a Gram-negative Hfq homologue.  Thus 
understanding how the sequence (G-G-A)5 is binding on the proximal face of E. coli Hfq 
warrants further investigation and necessitates high-resolution structures of this 
interaction.  The observation that the sequence (G-U)3G binds to the proximal face of L. 
monocytogenes is also intriguing and will warrant further study as there are no high 
resolution structures of G-rich sequences bound to L. monocytogenes on the proximal 
face.  The observation that both Gram-negative and Gram-positive Hfq homologues 
bind G-rich sequences on the proximal face is intriguing and may suggest that they have 
a similar binding mechanism. 
These data further emphasize the utility of the TFQ technique as it further 
demonstrates that this technique is capable of differentiating between the two different 
binding motifs that exist for E. coli and S. aureus.  This is best shown by the observation 
that in E. coli residue 31 is within 6 Å of the bound RNA but does not directly interact 
while for S. aureus residue 31 is the main residue involved in base stacking for the L-site 
and is quenched by cognate RNA (Figure 25).  Here the tested sequences for E. coli do 
not interact with residue 31, thus indicating that the observed binding motif, while now 
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more refined, utilizes the same pathway.  The tested sequences that bind to the distal 
face for S. aureus show strong binding to residue 31 indicating that for all distal face 
binding sequences this residue has a significant role in binding and these RNA 
sequences most likely use the same binding motif.     
 70 
 
4. Autoregulation of E. coli Hfq 
4.1 Introduction to Hfq Autoregulation 
Hfq homologues have been shown to regulate the expression of many different 
mRNA transcripts.  There are a variety of different mRNA transcripts that are regulated 
by a particular Hfq homologue however, not all homologues regulate the exact same 
transcripts.  It has been shown that E. coli and Sinorhizobium meliloti (S. meliloti) are 
involved in autoregulation.  Autoregulation means that the protein expressed from a 
particular mRNA transcript will feedback to control its own expression either raising, 
positive autoregulation, or lowering, negative autoregulation, its expression.  For both E. 
coli and S. meliloti Hfq negative autoregulation is observed meaning that when Hfq is  
 
Figure 33: S. meliloti Hfq β-galactosidase assay illustrating negative autoregulation 
β-galactosidase activity was assayed in vivo using S. meliloti strains 20PS15 (WT: 
filled circles), 20PS16 (hfq knockout strain: open circles), and 20PS16/phfqSm 
(complemented hfq knockout strain: filled square) that have been transformed to 
incorporate a sequence that uses the hfq promoter region to express the lacZ gene into 
the genome for performing a β-galactosidase assay.  Image taken from (7).   
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present it will bind to its own mRNA transcript and inhibit translation. For S. meliloti 
autoregulation has been observed in vivo (7).  The hfq promoter was used to control the 
lacZ gene.  It was observed that a wild-type strain of S. meliloti will maintain a constant 
level of β-galactosidase activity while in a strain of S. meliloti that has hfq deleted, the β- 
galactosidase activity significantly increases during growth (Figure 33) (7).  It was also 
determined that adding hfq back to the deletion strain will return β-galactosidase  
 
Figure 34: In vivo analysis of hfq mRNA transcript levels in E. coli Hfq null 
strain 
Amount and stability of the P1hfqHS, PmiaA and mutL-miaA transcripts in the E. coli 
hfq1 knockout strain as detected by RNase T2 protection assays.  Hfq1 is the Hfq 
null strain while hfq+ is the wild-type E. coli strain.  Time points were taken just 
before (-1), just after (0) and 1, 2.5, 4 and 6 minutes after addition of rifampicin.  
Transcript levels for both P1hfqHS and PmiaA remain constant in the hfq knockout 
strain while they disappear over time in the wild-type strain indicating that the 
presence of hfq causes those transcripts to disappear.  However the mutL-miaA 
transcript level does not change over time indicating that Hfq is not the cause for 
turnover of this transcript. Image taken from (64). 
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activity levels to the constant wild type levels (Figure 33) (7). Taken together these data 
indicate that S. meliloti Hfq negatively autoregulates itself.   
For E. coli negative autoregulation was demonstrated in vivo by carefully 
inserting a kanamycin cassette into the middle of the hfq gene within the genome and 
monitoring hfq transcript levels present during growth (64).  In wild type E. coli cells 
there is an initial detection of hfq and over time the transcript disappears, whereas in the 
Hfq null mutant the transcript level remains constant (Figure 34).  There are two binding 
sites within the 5’ untranslated region (5’ UTR) of E. coli hfq that have been shown to be 
important to the ability of Hfq to bind its mRNA transcript termed site A and site B 
(Figure 35).  These two binding sites were identified by gel shift mobility assays (65).   
 
Figure 35: E. coli 5’ UTR of hfq mRNA transcript  
The 5’ UTR sequence of hfq mRNA. The two identified Hfq binding sites, Site A 
and Site B, are highlighted with thin red boxes while the sequence termed 5’ UTR 
is highlighted with a thick red box.  The start codon of the hfq gene is indicated 
by the black arrow. Image adapted from (34). 
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Furthermore it has been determined in vitro that having Hfq in an in vitro translation 
initiation assay will prevent translation initiation, most likely by blocking the ribosome 
binding site (Figure 36) (65).  The observation that there are two binding sites would 
suggest that each site will bind to a particular face of Hfq.  To date no high-resolution 
structure has been obtained that shows how these two binding sites interact with Hfq.  
Understanding how E. coli Hfq binds to its 5’ UTR, which is important for 
autoregulation, will improve our knowledge of how Hfq functions in vivo.  By 
improving our knowledge of how Hfq autoregulates it may become possible to control 
Hfq autoregulation and to then potentially target Hfq levels as part of drug therapy 
treatment against multidrug resistant bacteria. 
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Figure 36: Translation initiation of hfq with and without hfq (34) 
Toeprinting assay to illustrate autogenous inhibition of translation initiation by Hfq. 
Lane 1, primer extension in the absence of 30S subunits, tRNAfMet and Hfq. Lane 2, 
toeprinting in the presence of 30S subunits, tRNAfMet, and absence of Hfq. Lanes 3–5, 
toeprinting with 30S subunits, tRNAfMet, and increasing molar Hfq-hexamer ratios to hfq 
mRNA as indicated at the top of the autoradiograph. Hfq was added prior to the 
addition of ribosomes. On the left the arrowhead depicts the toeprint signal at position 
+15 relative to the A of the ATG start codon. The relevant part of the DNA sequence of 
the hfq 5’ UTR along with the position of the Shine-Dalgarno (SD) sequence and the ATG 
start codon are all shown on the right.  Image taken from (65) 
 
4.2 Hfq mRNA Site A, Site B and 5’ UTR  
To understand how the identified binding sites interact with E. coli Hfq three 
different RNA sequences were used, Site A (5’ –  
AUUUUUUCAGAAUCGAAAGGUUCA – 3’) which contains site A and the following 
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stem loop, Site B (5' – GCAUAUAAGGAAAAGAGAGAAUGG – 3') and 5’ UTR which 
contains all of site A and site B along with the native linker that is between them (Figure 
35).  Site A and site B were ordered as synthetic oligomers while 5’ UTR was generated 
using T7 RNA polymerase.  To ensure that the proper secondary structures were formed 
these RNA oligonucleotides were boiled for 5 minutes and then snap cooled on ice.  
These sequences were then used in the TFQ assay to study their interactions with E. coli 
Hfq.  Since these sequences only interact with E. coli Hfq the S. aureus and L. 
monocytogenes mutants were not utilized in this study. 
The site A containing oligoribonucleotide was observed to significantly quench 
residues Q33W, F39W, F42W, G77W and Y83W.  This suggests that site A is capable of 
binding to both faces with a preference for binding to the proximal face (Figure 37A).  
The quenching results also indicate that site A quenches two C-terminal tail residues, 
suggesting a potential interaction between those residues and site A.  Y83W was also 
quenched by (G-G-A)5, which bound on the proximal face, potentially suggesting that 
RNA sequences bound on the proximal face of sufficient length will interact with the 
tail.  The site B oligoribonucleotide was observed to quench F11W, Y25W, Q33W, F39W, 
F42W, and Y83W (Figure 37B).  A preference for distal face binding was observed for 
site B since the proximal face residues do not quench until the higher 4 µM RNA 
concentration is reached while the distal face residues quench at the lower 1 µM RNA 
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concentration.  Site B is also observed to quench the C-terminal Y83W mutant indicating 
that this longer RNA sequence interacts with the C-terminal tail.  The behavior of these  
 
Figure 37: E. coli Hfq TFQ using hfq site A and site B. 
TFQ using the hfq mRNA sites known for Hfq binding termed site A and site B.  
1 = F11W, 2 = R17W, 3 = Y25W, 4 = K31W, 5 = Q33W, 6 = F39W, 7 = F42W, 8 = 
G77W, 9 = Y83W, 10 = Q95W. These graphs illustrate that site A can bind to both 
faces with a preference for binding to the proximal face while site B, which can 
also bind to both faces, preferentially binds to the distal face.   
 
ligands suggest that it will be possible for both sequences to simultaneously bind to Hfq.  
To determine if these two sites would compete for a particular face TFQ assays were 
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done where an initial 1 µM titration of one site was done and then the other site was 
titrated to a final concentration of 4 µM (Figure 38).  These assays were done using  
 
Figure 38: TFQ competition assays using hfq mRNA site A and site B 
TFQ competition assays using the hfq mRNA sites known for Hfq binding 
termed site A and site B.  These graphs illustrate that the two sites do not appear 
to compete for binding to a particular face.   
 
the full length E. coli Hfq Y25W and F42W mutants to analyze binding on each face.  For 
E. coli Hfq Y25W it was observed that when Site B was initially titrated followed by Site 
A there was an initial quench followed by only small increases in quenching as would be 
expected if Site A were not competing for binding (Figure 38).  The reverse titration 
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where Site A was initially titrated followed by Site B showed a small initial quench 
followed by more significant quenching also indicating that no competition appears to 
exist for distal face binding (Figure 38).  E. coli Hfq F42W was also observed to not 
experience significant competition for binding (Figure 38).  This suggests that the two 
sequences are not in competition for binding to the faces but rather will bind to opposite 
faces, most likely binding to the face that each site prefers. 
 
Figure 39: E. coli Hfq TFQ using 5’ UTR. 
TFQ using the hfq mRNA 5’ UTR, which contains both site A and site B.  1 = 
F11W, 2 = R17W, 3 = Y25W, 4 = K31W, 5 = Q33W, 6 = F39W, 7 = F42W, 8 = G77W, 
9 = Y83W, 10 = Q95W.  These graphs illustrate that the 5’ UTR binds to both faces 
with a preference for the proximal face at higher RNA concentrations.  These 
graphs also show that the longer, more structured 5’ UTR is capable of binding 
the entire C-terminal tail and to the proposed lateral binding site (R17W). 
 
Since there appears to be no competition for binding to the two faces the two  
sites, site A and site B, were connected using the native linker sequence and that 
sequence is termed the 5’ UTR.  This construct was synthesized biochemically and used 
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for TFQ (Figure 39).  The 5’ UTR sequence quenches all residues to varying extents.  
Both faces show significant quenching indicating that 5’ UTR binds to both faces with 
perhaps a preference for the proximal face.  The 5’ UTR also quenches all three C-
terminal tail residues, G77W, Y83W and Q95W indicating that this significantly longer 
RNA sequence appears able to interact with the full length of the C-terminal tail.  Finally 
the 5’ UTR quenches R17W which has previously not been observed.  R17W resides at 
the C-terminal end of the N-terminal α-helix on the proximal face.  Through our TFQ 
experiments we have not observed any other interactions with R17W, however, Sauer et 
al (52) and Panja et al (66) have proposed a role for residues R16 & R17 in RhyB and rpoS 
binding and have proposed that these residues participate in a third “lateral” binding 
site.  From our observation here it is suggested that longer, more structured RNA 
sequences may be required for binding to occur at this proposed lateral binding site.  
This may also suggest that the determined binding mechanisms may not be elucidating 
the complete binding mechanism for these longer, more structured RNA but rather are 
illustrating how RNA interacts on a particular face whether it fully or only partially 
occupies the known binding sites for a given face.   
4.3 Proposed Binding Modes of 5’ UTR to Hfq  
The above results suggest two different potential binding models of the E. coli hfq 
mRNA 5’ UTR to E. coli Hfq (Figure 40).  The first model (Figure 40A) hypothesizes that 
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a single 5’ UTR binds to a single Hfq hexamer with site A, which contains the stem loop, 
binding to the proximal face, site B binding to the distal face and the linker region 
wrapping around the hexamer thus interacting with the lateral binding site.  The second 
model (Figure 40B) shows two 5’ UTR binding to a single Hfq hexamer where one 5’ 
UTR is interacting with the proximal face using its site A while the second 5’ UTR is 
interacting with the distal face via its site B.  Both of these models fit the observed data. 
 
Figure 40: Proposed models for E. coli hfq mRNA 5’ UTR binding to E. coli Hfq. 
Models that satisfy the observed TFQ data for how 5’ UTR interacts with E. coli 
Hfq.  A) A single 5’ UTR interacting with the Hfq hexamer B) Two 5’ UTR 
interacting with the Hfq hexamer. 
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4.4 Conclusions and Future Directions 
TFQ has been used to examine how hfq mRNA interacts with E. coli Hfq.  It is 
shown that the two known binding sites from the 5’ UTR of hfq mRNA do bind to Hfq.  
Both sequences are capable of binding to both faces however they each show a 
preference for one face, site A preferring the proximal face while site B prefers the distal 
face.  These two sites do not appear to compete for binding to a particular face, however 
the competition assay performed here has flaws.  To truly know if there is competition 
between the two sites for Hfq a more thorough competition assay will need to be 
performed.  When the two sites are linked together as found naturally in the 5’ UTR of 
hfq mRNA TFQ is observed to occur on both faces with a potential preference for 
proximal face binding.  The observed TFQ pattern may suggest that site A contributes to 
binding more than site B, although site B does contribute since total TFQ levels are 
higher than observed for site A binding alone.  Using the 5’ UTR for TFQ also causes all 
tested C-terminal residues to quench, which has not been previously observed.  This 
indicates that the C-terminal tail residues are involved in RNA binding, however it does 
not indicate the importance of these residues for binding strength.  To determine the 
relevance of the residues to hfq mRNA binding the binding affinity should be 
determined using alanine point mutants.  TFQ with the 5’ UTR also shows quenching of 
R17W which has not been observed for any other tested RNA sequence.  This indicates 
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that the proposed lateral binding site interacts with RNA.  Since TFQ for R17W was 
observed only for our longest, most structured RNA sequence binding to R17W appears 
to require longer, structured RNA to interact, which is in agreement with the 
conclusions from Sauer et al (52) and Panja et al (66).  Taken together the hfq mRNA TFQ 
suggests two different potential binding modes as shown in Figure 40.  The difference 
between the two models resides around whether or not hfq mRNA is binding to Hfq in a 
1:1 or 2:1 ratio.  There are several techniques that can be used to determine the 
stoichiometry of binding including gel shift assays, FP, isothermal calorimetry and size 
exclusion chromatography.  Hfq does not required a sRNA to block ribosome binding to 
hfq mRNA thus suggesting the mechanism of action for negative autoregulation follows 
the known mechanism proposed in Figure 1E where a mRNA binds to hfq mRNA, 
promotes PAP polyadenylating the mRNA and degradation by an exonuclease.  The 
observed binding of Hfq to hfq mRNA by TFQ indicates the Shine-Dalgarno sequence 
will be blocked and that the 3’ end of the RNA will be open for modification and 3’-5’ 
degradation by an exonuclease. 
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5. Conclusions and Future Directions 
5.1 Conclusions 
Hfq is a known RNA chaperone that facilitates sRNA/mRNA pairing.  Hfq 
interacts with many different sRNA/mRNA pairs leading to Hfq regulating many 
different cellular pathways, including multiple stress responses, quorum sensing, 
virulence, multidrug resistance and maintenance of membrane integrity.  In many 
bacterial species the deletion of Hfq causes pleiotropic effects including loss of virulence, 
larger cell size, slower growth, etc (4-9).  The mode of RNA interaction with Hfq has 
been well studied using x-ray crystallography, identifying two binding faces, distal and 
proximal (38, 41-46).  However, these structures all use short RNA sequences that 
typically are derived from a longer, more complex physiologically relevant RNA.  These 
structures also often use a truncated form of Hfq that removes the highly variable C-
terminus.  In order to examine how larger RNA sequences interact with Hfq SAXS 
studies have been performed (36, 49, 50).  The SAXS studies suggest that larger RNA 
strands bind a single face of Hfq (49, 50), however to determine which face those RNA 
sequences were actually binding other experiments, such as NMR spectroscopy, had to 
be performed.   
Here a quick, straightforward method for analyzing Hfq-RNA interactions has 
been presented.  Using the fact that Hfq natively does not contain Trp it is possible to 
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use structure guided design to introduce Trp point mutants in Hfq.  Since Trp fluoresces 
it is possible to study Hfq binding to RNA as RNA will quench Trp fluorescence when 
the two interact.  Using known binding sequences, A15 and U6, as control experiments 
TFQ has been shown to properly identify Hfq-RNA interactions.  Specifically it was 
observed that A15 will bind to the distal face of both E. coli and S. aureus Hfq and U6 will 
bind to the proximal face of E. coli and L. monocytogenes Hfq.  To ensure that TFQ occurs 
only when RNA and Trp directly interact, the Trp residue mimetic NAT was used.  No 
quenching of NAT was observed with either control sequence which demonstrates the 
necessity of a direct interaction between RNA and Trp to observe quenching.   
Further controls were performed to determine what effect the Trp mutants may 
have on Hfq function and structure.  It was observed that a Trp mutation on a binding 
face lowers binding for RNA sequences that bind to that mutated face, which may lead 
to false negatives.  However it was also observed that these Trp mutants do still bind to 
their RNA sequences and TFQ is still detected so this lower affinity is not a priori 
detrimental to the interpretation of TFQ data.  It is also noted that binding face Trp 
mutants do not affect binding for RNA sequences that are not expected to bind to that 
face.  Crystal structures were obtained for four of the E. coli Trp mutants using the 
truncated form of E. coli Hfq (residues 2-69).  Overall these structures demonstrate that 
mutating residues to Trp does not significantly alter the structure of Hfq.  The F11W 
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structure does vary somewhat from wild type when comparing hexamer:hexamer, 
which appears to be a result of significant shortening of β strands 2 and 5 caused by the 
bulky nature of the Trp side chain.  β-strands 2 and 5 make up the distal side 
intersubunit interface and shortening those causes a distortion in hexamer packing 
leading to a larger RMSD between wild type and F11W.  The Y25W structure provides 
reasoning for the significantly weaker binding to A15 (a 184-fold worse binding).  In this 
structure it is seen that the Trp side chain can take two different rotamers, the first 
rotamer places the indole side chain in the same physical space that adenosine packs 
into while the second rotamer clashes with the 2’-OH of the RNA substrate.  This implies 
that for the RNA sequence to bind reorganization of the local structure must occur 
which causes the observed lower binding affinity. 
Gram-negative and Gram-positive Hfq homologs have been shown to have 
different distal face binding motifs.  Gram-negative Hfq (E. coli) has an (A-R-N)n motif 
while Gram-positive Hfq (S. aureus and B. subtilis) have an (R-L)n motif.  The R-site for 
both Gram-negative and Gram-positive Hfq has been hypothesized to actually be an A-
site due to the fact that all germane crystal structures have adenosine bound in that site, 
however since it is possible to computationally model a guanosine in the R-site of the E. 
coli crystal structure the sites cannot be defined as adenosine only sites.  Binding assays 
have been performed that indicate Hfq does indeed bind to (A-R-N)n or (R-L)n 
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sequences, however, these assays cannot provide insight into where the interaction 
occurs.  Thus, to further investigate the proposed motifs TFQ was applied.  TFQ data 
indicates that the Gram-negative E. coli Hfq homologue distal face binding motif is (A-
A-N)n and that the Gram-positive S. aureus Hfq homologues distal face motif is (A-L)n.  
This was determined by using sequences that fulfilled both an (A-R-N)n and (A-A-N)n 
motif or just an (A-R-N)n motif or sequences that fulfilled either an (R-L)n and (A-L)n 
motif or just an (R-L)n motif.  It was observed that only the sequences that fulfilled both 
motifs would bind to the distal face while those that fulfilled only the (A-R-N)n or (R-L)n 
motifs will not bind the distal face but may bind the proximal face.  The observation that 
some (A-R-N)n and (R-L)n motifs bind to the proximal face is quite interesting and 
further high resolution structural studies will be pursued to elucidate how these 
sequences are binding. 
Finally TFQ was used to study the interaction of E. coli Hfq with hfq mRNA.  E. 
coli Hfq has been shown to negatively autoregulate its own translation by binding to two 
sites, site A and site B, within its 5’ UTR.  Using TFQ it has been shown that both sites 
are capable of binding to both faces, however, each site shows a preference for one face.  
Site A prefers binding to the proximal face while site B prefers the distal face.  When the 
two RNA sequences are joined together via their native linker to create the RNA 
substrate referred to as 5’ UTR it is observed that the 64 nucleotide sequence binds to 
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both faces.  These data allow two potential models to be proposed that describes how hfq 
RNA binds to Hfq.  The first model hypothesizes that a single 5’ UTR binds a single Hfq 
hexamer such that site A binds to the proximal face, the linker wraps around Hfq and 
site B binds the distal face.  The second model proposes that two 5’ UTRs bind a single 
Hfq hexamer with one binding to the proximal face via its site A and the other binding 
the distal face via its site B.  These two models can be differentiated by calculating the 
stoichiometry of binding by ITC or size exclusion chromatography.  The 5’ UTR is also 
observed to bind to the recently proposed lateral binding site.  TFQ does not detect 
binding at this site for any other RNA sequence suggesting that a longer and potentially 
more structured RNA is required to detect binding here.  Finally, binding is observed for 
the C-terminus out to reside 95 using the 5’ UTR substrate suggesting a longer, more 
structured RNA sequence will interact with the C-terminus.  
5.2 Future Directions 
TFQ has been shown to be a useful assay for mapping the RNA binding sites on 
Hfq.  With this technique in hand the next step is to begin analyzing how the vast array 
of physiologically relevant RNA sequences bind Hfq.  Some of these target RNA 
sequences will include the Spot 42 – galK pairing.  Spot 42 is a sRNA that downregulates 
the mRNA galK, which encodes the third gene of the galactose operon.  Another 
sRNA/mRNA pair that can be studied is RhyB/sodB. RhyB will bind to sodB and 
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downregulates the level of sodB in the cell.  SodB encodes superoxide dismutase, which 
catalyzes the dismutation of superoxide into oxygen and hydrogen peroxide.  There are 
many different sRNA/mRNA pairs that can be studied and an examination of several 
different sRNA and mRNA pairs will be performed to understand how these RNA 
sequences interact with Hfq. 
It would be of great interest to expand this method to analyze the proposed 
“Active cycling” model to analyze how known RNA sequences compete for binding to 
Hfq.  One way to expand TFQ to be able to study the “Active cycling” model is to apply 
Fluorescence Resonance Energy Transfer (FRET) to TFQ.  The goal here would be to 
examine the current hypothesis that two RNA sequences that bind to the same face on 
Hfq will actually compete for binding on that face.  In this assay the Hfq Trp mutants 
would be used with two RNA strands.  One RNA sequence would have a fluorophore, 
such as AlexaFluor 350, attached to it while the other RNA sequence will be unlabeled.  
The Trp mutant would be detected using a spectrophotofluorometer, and then the 
unlabeled RNA would be titrated in to check for TFQ.  Once TFQ has been established 
the labeled RNA substrate would be titrated into the sample.  Excitation would still be 
targeted at the Trp but now emission will be examined in AlexaFluor 350s range (442 
nm).  If the RNA strand is capable of competing off the bound substrate FRET will occur, 
if it is not or if it binds to the opposite face of Hfq, then no FRET will be observed.  
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Expanding the TFQ assay in this way will provide a technique for directly observing 
RNA substrates competing for binding to Hfq.  The current methods for analyzing RNA 
cycling on Hfq only indirectly observe which face an RNA sequence is binding to.  
Currently it has been observed that many RNAs are capable of displacing RNA on either 
face. 
To further validate TFQ, crystal structures of the Trp mutants bound to RNA 
substrates should be determined, along with solving apo structures for all Trp mutants.   
Determining these structures will further demonstrate that TFQ properly identifies how 
an RNA sequence binds to Hfq without altering the known RNA-Hfq interactions. 
Studies concerning the distal face binding motif for both Gram-negative and 
Gram-positive Hfq homologues have raised some interesting questions.  The first 
question that needs follow up relates to how (G-G-A)5 binds to E. coli Hfq and (G-U)3G 
binds to L. monocytogenes Hfq.  TFQ indicates that these sequences bind to the proximal 
face, which was not the expected binding face.  These sequences do not have poly-U 
sequences in them, although the (G-U)3G does at least have uridine, which is the 
nucleotide that typically binds on the proximal face.  Therefore to fully understand how 
these sequences are binding Hfq high-resolution crystallography studies will be 
pursued.  
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To date one hypothesis concerning Hfq is that the differential distal face motifs 
are related to the bacterial species origin of a given homologue.  Those that originate 
from Gram-negative bacteria will display an (A-A-N)n motif while those from Gram-
positive will display an (A-L)n motif.  This is supported by a few crystal structures and 
the TFQ data presented here.  However, the structures and TFQ data each only use a 
single Gram-negative and two Gram-positive homologs.  To truly expand these 
observed motifs to these groups other Hfq homologs should be used, such as S. 
typhimurium for Gram-negative and L. monocytogenes for Gram-positive Hfq.  TFQ can 
easily be applied to other Hfq homologues simply by creating the desired Trp mutants 
based on sequence alignment and these Trp mutants can then be used to determine if 
the proposed distal face motifs are truly universal.  For Gram-positive Hfq homologues 
it is useful to study homologs other than S. aureus as it is currently controversial whether 
or not Hfq is important to S. aureus.  As such Trp mutants have already been created in 
L. monocytogenes using sequence alignment with S. aureus to guide the Trp mutant 
design process.  These mutants are currently being taken through TFQ. 
Finally, TFQ has demonstrated how the proposed binding sites for the 5’ UTR hfq 
mRNA interacts with Hfq.  It has been shown that this RNA is capable of binding to 
both faces.  It is necessary to determine the stoichiometry of binding for the 5’ UTR to 
Hfq to know if this RNA is capable of wrapping around Hfq as has been proposed.  It is 
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also of interest to design variants of the 5’ UTR that has one of the binding sites 
abolished.  By knocking out one site or the other it can be determined if a particular site 
is more important for 5’ UTR binding to Hfq. 
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Appendix 
In-cell NMR Spectroscopy Using E. coli 
Within a cell, there are many different proteins, other biological macromolecules 
and small molecules that must function properly in order for a cell to survive.  The 
simplest organisms are estimated to use a few hundred small molecules and encode up 
to 1,000 different proteins (67, 68), with the human genome expected to encode 10-100 
fold more (69).  The large number and diversity of small molecules and biological 
macromolecules form a cellular environment that is very crowded and complex (70) 
(Figure 41).  Understanding the influence that this packed environment has on protein 
 
Figure 41: Illustration of the crowded intracellular environment of an E. coli cell 
This image depicts the current thought about the environment, crowded and 
complex, that the many known biological macromolecules and small molecules 
of an E. coli cell experience (70). 
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structure, stability and behavior as well as on protein complexes is one of contemporary 
biochemical sciences challenges  (67, 71, 72).  The knowledge that can be gained from 
complete molecular- and atomic-level observations is invaluable to understanding 
detailed protein mechanisms of action as well as in the areas of drug development, 
protein engineering and numerous other research frontiers.  
In-cell Nuclear Magnetic Resonance Spectroscopy (NMR) is a technique used to 
study proteins at atomic-level resolution within living cells (70).  The ultimate goals are 
3D molecular structure determination and examining binding interactions.  Historically, 
structure determination, both X-ray crystallography and NMR spectroscopy, has been 
done only on purified proteins.  The fact that NMR is a noninvasive solution technique 
suggests that NMR is uniquely suited to studying full atomic-level macromolecular 
structures in a representative environment, although not necessarily a natural 
environment (72).  The strength of in-cell NMR spectroscopy lies not only in its ability to 
determine de novo three dimensional (3-D) structures, but also in its ability to observe 
structural changes of biological macromolecules in a native environment.  Structural 
changes can be directly observed by monitoring changes that occur in a protein two 
dimensional (2-D) 1H-15N (or 1H-13C) heteronuclear single quantum coherence (HSQC) 
fingerprint spectrum, since every protein generates a unique 1H-15N (or 1H-13C) HSQC 
that is dependent on secondary, tertiary and quaternary structure along with the 
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chemical environment that the protein resides in. Alterations in the structure of the 
target protein or its chemical environment cause changes in the 2-D fingerprint.  This 
enables studies of molecular interactions within a living cell, such as mapping the 
binding interface between two proteins (73). 
In-cell NMR spectroscopy within E. coli has been used to determine the 3-D 
backbone assignment of GB1(74), determine the de novo 3-D structure of gene product 
TTHA1718 (75, 76) as well as to study protein-DNA interactions (77), protein-protein 
interactions (73), binding events (78) and to identify potential new drugs (79).  NMR is 
dependent on nuclei that have nuclear spin such as a proton (1H) whose nuclear spin 
angular momentum quantum number (I) is ½.  Other common nuclei used for 
biochemical NMR spectroscopy include nitrogen (N) and carbon (C), which exist as 14N 
and 12C isotopes 99.6% and 99.0% of the time respectively, have I equal to 1 because they 
have an even mass number and an even atomic number.  An I of 1 is NMR inactive as it 
does not have nuclear spin. Since N and C are the main atoms used for building proteins 
it is necessary to be able to detect these atoms via NMR, thus the stable isotopes 15N and 
13C (occurring 0.4% and 1% of the time, respectively), which have I equal to ½, are 
incorporated into molecules of interest.  Both uniform and selective methyl-group 
labeling strategies have been applied (80, 81).  Labeling schemes typically use isotope 
15N enrichment for 2-D fingerprint data collection and also incorporate uniform isotope 
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13C labeling when collecting 3-D data for assignment and structure determination. The 
1H-13C HSQC fingerprint can also be useful but it is often complicated by significant 
background noise arising from incorporation of 13C into cellular metabolites by the cell 
when the protein of interest is overexpressed within the cell of interest (81).  However, it 
has been demonstrated that utilizing specific 13C methyl-group labeling can be beneficial 
for observing large proteins that have attenuated 1H-15N HSQC spectra since methyl 
groups most often have independent rotational motion and give better line shape and 
intensity (81-83).  An alternative specific labeling strategy is to incorporate 19F as an 
NMR probe, which can enhance sensitivity (84), but typically does not provide sufficient 
data for structural characterization. 
Protein that aggregates or interacts with the cellular membrane, DNA, or large 
protein complexes may have significantly longer rotational correlation times due to 
slower molecular motions and/ or may be involved in an intermediate exchange regime.  
This can lead to NMR signal attenuation due to line broadening, thus making the 
protein quite difficult to detect and often making the protein “invisible” by in-cell NMR 
spectroscopy.  This was found to be the case for the MetJ repressor protein, which binds 
nonspecifically to DNA (77).   
Recently it has been suggested that the overall charge of a protein will indicate 
the ability to detect a protein by in-cell NMR spectroscopy where only proteins with an 
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overall negative charge in the E. coli cellular environment, having a pI at or below 4.5, 
will be detected and proteins that are neutral or positively charged will not be detected 
(85).  This is expected since 40-70% of native E. coli proteins are negatively charged along 
with the cellular environment containing the large negatively charged nucleoid and 
lipid membrane. 
2-D HSQC spectra can be very useful when the in vitro assignments for the 
protein are already known.  The fingerprints obtained from the in-cell NMR experiment 
can often be compared to the in vitro spectrum to obtain the assignments unless the 
structure within the cell is different from the in vitro structure.  So far, most in-cell NMR 
HSQC spectra have shown only slight differences when compared to the in vitro 
spectrum, so it is straightforward to transfer the assignments.  This also indicates that 
the molecular crowding and corresponding limited protein-accessible free volume 
characteristic of the intracellular milieu are not significant determinants of the folded 
state.  With the HSQC spectrum assigned it is straightforward to study how specific 
changes within the cellular environment affect protein structure.  Through examination 
of 2-D 1H-15N HSQC experiments it is possible to study how drugs bind to the protein of 
interest within the cellular environment (78), and to identify potential new drugs (79).  It 
is also possible to study protein-protein interactions (73) and to study the effect that a 
post-translational modification on one of the binding partners may have on the binding 
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interface (86).  Even the effect of nonselective protein-DNA interactions on the NMR 
spectrum has been studied by in-cell NMR spectroscopy, leading to new insights into 
repressor activity in transcription regulation (77).  In-cell NMR spectra have also shown 
that some, although not all, intrinsically disordered proteins may gain structure within 
the cellular environment (87, 88).  These studies utilizing the 2-D 1H-15N HSQC 
experiments, illustrate the diversity and strength of in-cell NMR spectroscopy to expand 
the knowledge of protein function within a living cell. 
 When 2-D HSQC assignments have not been previously determined in vitro or 
when significant differences between the two HSQC spectra are observed it becomes 
necessary to collect additional multidimensional experiments.  There are time limitations 
that can significantly impact the ability to collect multidimensional NMR data as cells do 
not remain viable, or evenly distributed, within an NMR tube over the time it takes to 
collect a standard 3-D NMR experiment.  These time limitations make it necessary to 
utilize fast NMR methodologies and ultrasensitive probes that are continuing to be 
developed and improved.   
Cryogenically cooled probes have improved the signal to noise ratio 2-4 fold that 
of conventional room temperature probes.  This improvement is achieved by cooling the 
RF coils down to 15-30 K, which results in reduced resistance in the coils, lower thermal 
noise and increased probe quality factor.  These probes extend the protein concentration 
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range that can be detected down to 100 µM or less, or reduce the acquisition time by the 
sensitivity gain factor squared.  Thus cryo-probes aid in detecting protein within a live 
cell by lowering the required detection limits, however the cryo-probes on their own are 
not sufficient for collecting multidimensional NMR data using live E. coli cells.  Thus fast 
NMR methodologies are also required. 
There are several ways to collect fast NMR data (89-92); however, to date only 
sparse sampling techniques have been used for in-cell NMR spectroscopy.  Most fast  
 
Figure 42: Schematic of the differences between conventional and fast NMR data 
collection strategies. 
F3 is the directly detected dimension. In a conventional experiment (A), data are 
collected by holding F2 to a constant and incrementing in the F3 dimension.  
Projection Reconstruction (PR-NMR) (B) has two orthogonal planes, F1,F3 and 
F1,F2 with radial projections from the origin formed by the intersection of two 
orthogonals.  The angle α is defined by the rate of incrementation of the indirect 
evolution times. 
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NMR methodologies require two aspects to be considered: the sampling pattern used 
and the processing method applied.  The sampling patterns used for fast NMR are 
designed to reduce the number of points sampled to significantly reduce the data 
collection time for a specific NMR experiment when compared to the standard Cartesian 
sampling pattern.  Sparse sampling patterns used for multidimensional NMR include a 
radial sampling pattern (92, 93), concentric ring sampling (94) and random sampling 
(95).  Radial sampling is a special case of concentric ring sampling, where the same 
number of points is taken for each ring (Figure 42).  Random sampling involves 
collecting data points that are distributed randomly.  These patterns are different from 
the standard Cartesian grid sampling pattern as Cartesian sampling distributes the data 
points equally on a grid while these other sampling patterns either are not on a grid at 
all or, if positioned to be on a grid, only partially fill it. 
The other aspect of performing fast NMR experiments is the ability to properly 
process the data.  There are several processing methods available (95-102).  The 
sampling pattern chosen can lead to artifacts being incorporated in the spectrum upon 
processing.  It is well-known that radial sampling produces artifacts.  As a result the 
field has moved away from radial sampling towards random concentric ring sampling 
(103).  In any of the methods used it is important to appreciate the potential for 
introducing artifacts in the processed data collected from fast NMR experiments. 
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Currently two in-cell NMR studies have been performed using these fast NMR 
techniques.  The first study used Projection-Reconstruction NMR (PR-NMR) with radial 
sampling and the hybrid back-projection/lower-value (HBLV) reconstruction algorithm 
to walk the backbone of GB1 (74).  The backbone assignment of GB1 was accomplished 
by collecting PR-NMR versions of the 3-D HNCA, HNCO and HA(CA)NH experiments.  
The second study used random sampling followed by maximum entropy processing 
(75).  The 3-D structure of TTHA1718 was determined using several 3-D heteronuclear 
NMR experiments and distance restraints obtained from NOE data. 
To enhance the understanding of what factors contribute to successful detection 
of a protein within a living cell by in-cell NMR we pursue the question of how a proteins 
charge may affect detection by studying how the standard purification tag of 6 His 
residues affects detection of GB1.  We also explore detection of Ubiquitin, which has 
been reported in the literature but is difficult to reproduce.  Currently the largest protein 
that has been detected by in-cell NMR spectroscopy is calmodulin at 16.8 kDa. To 
determine size limitations we attempt to observe enhanced green fluorescent protein 
(EGFP), a 27kDA monomer that has a weak dimerization tendency at concentrations 
above 5 mg/mL.  Finally, to further understand Protein-DNA interactions, Catabolite 
activator protein will be examined by in-cell NMR spectroscopy with the goal being to 
study its DNA binding interactions in vivo. 
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Experimental Procedures 
Gb1, Gb1-His, Ubiquitin, EGFP and CAP plasmid constructs – The GB1 vector was provided 
by Dr. Patrick Reardon and selected for using 100 µg/mL Ampicillin. The GB1-his vector 
was provided by Dr. Pei Zhou’s lab and selected for using 25 µg/mL Kanamycin. 
Ubiquitin was provided by Dr. Patrick Reardon and selected for using 100 µg/mL 
Ampicillin.  Standard mutagenesis methods were employed to create 3A-Ubiquitin.  The 
pGLO vector was provided by Dr. Anne Marie Augustus and selected for using 100 
µg/mL Ampicillin.  Standard cloning techniques were used to create pET41b-EGFP, 
which was selected for using 25 µg/mL Kanamycin.  The mYPET vector was provided by 
Dr. Tomoo Ohashi and selected for using 100 µg/mL Ampicillin. The Catabolite activator 
protein (CAP) was provided by Dr. Charalampos Kalodimos and selected for using 100 
µg/mL Ampicillin. 
Protein expression for in-cell NMR studies – The desired protein was transformed into E. 
coli BL21 DE3 cells and plated on LB Agar plates containing the appropriate antibiotic as 
listed above.  A 5 mL LB media growth was inoculated using a single colony and grown 
for 16-20 hours at 37 oC with shaking at 200 r.p.m. A glycerol stock was saved from the 
16-20 hour growth by taking 800 µL of the growth and adding 200 µL of 80% glycerol, 
flash freezing in a dry ice/ethanol bath and storing at -80 oC. All subsequent 16-20 hour 
growths were inoculated from the glycerol stock.  
 102 
 
2 50 mL modified M9 minimal media (Table 4) growths were inoculated from a 
16-20 hour growth to a starting optical density at 600 nM (OD600) of 0.05. Growths 
containing the expression vector for either GB1, GB1-His or CAP were then grown at 37 
oC while shaking at 200 r.p.m. to an OD600 between 0.4 and 0.6.  Cells were then 
harvested at 1,000 x g for 15 minutes, and then resuspended in fresh modified M9 
minimal media containing 1 g/L of 15NH4Cl and 2 g/L 12C-Glucose.  Cells were allowed to 
grow for 10 minutes and then expression of the protein was induced using 1 mM 
Isopropyl-β-D-1-thiogalactopyranoside (IPTG) and grown at 37 oC with shaking at 200 
r.p.m. for 4-6 hours.  After 4 hours of expression one growth was harvested at 1,000 x g 
for 15 minutes at 4 0C.  The cell pellet volume was estimated using known volumes of 
water and then the pellet was resuspended to a 20 % cell slurry in modified M9 minimal 
media containing 10% D2O.  This sample was used to tune and shim the NMR 
instrument.  After 6 hours of expression the second growth was harvested at 1,000 x g 
for 15 minutes at 4 oC.  This sample was resuspended in the same manner as the first 
sample.  This second sample was then used to collect the desired NMR experiment.  If 
protein signal was detected then the sample was removed from the NMR tube, the cells 
spun out at 1,000 x g for 10 minutes and the supernatant placed into the NMR tube.  The 
exact same NMR experiment was collected on the supernatant to ensure that the 
observed protein signal resides within the cells and not outside the cells.  If protein  
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Table 5: Modified M9 Minimal Media Composition 
Component Concentration 
Sodium Phosphate (Dibasic) 80 mM 
Potassium Phosphate (Monobasic) 40 mM 
NaCl 8.6 mM 
MgSO4 2 mM 
FeCl3 1 µM 
ZnSO4 25 µM 
CaCl2 100 µM 
H3BO3 2 µM 
CuSO4 2 µM 
CoCl2 2 µM 
MnCl2 10 µM 
NiSO4 2 µM 
(NH4)6Mo7O24 2 µM 
(NH4)Cl 0.1% (w/v) 
Glucose 0.2% (w/v) 
signal was not detected then the cells were lysed by freeze-thaw and the cleared lysate 
was examined for protein signal to see if protein expression levels were sufficient for 
detection. 
Expression for EGFP, mYPET and ubiquitin was done by growing 2 50 mL 
modified M9 minimal media samples at 37 oC with shaking at 200 r.p.m. until OD600 
reached between 0.4 and 0.6.  Expression was then induced using 1 mM IPTG and cells 
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were grown at 15 0C for 16-20 hours.  The two samples were prepared and used in the 
same manner as those for GB1, GB1-his and CAP. 
Freeze-thaw cell lysis – If no protein signal was detected after the desired NMR 
experiment is collected then the cell slurry is removed the NMR tube, the cells harvested 
and resuspended in an equal volume of lysis buffer (50 mM Phosphate buffer pH 7.0, 
300 mM NaCl, 2 mM PMSF, 2 µg/mL Deoxyribonuclase I (DNase I), 1.5 mg/mL 
lysozyme).  Cells were then frozen in a dry ice/ethanol bath for 5 minutes, removed and 
allowed to thaw at room temperature.  Cells were frozen and thawed two more times. 
The insoluble debris was spun out at 16,000 x g for 10 minutes at 25 oC.  The supernatant 
was removed, 10% (v/v) D2O added and the desired NMR experiment collected. 
NMR data collection – NMR spectra were collected on either a Varian 600 MHz or 800 
MHz Innova spectrometer equipped with a H,C,N cryogenically cooled triple resonance 
probe.  All spectra were processed with nmrPipe and visualized with nmrView (104, 
105). 
CAP purification – E. coli cells expressing WT-CAP were lysed using Bugbuster (EMD 
Millipore, Billerica, MA) containing 25 µg/mL DNase following the standard protocol.  
The lysate was then spun at 15,000 x g for 30 minutes at 4oC.  The clarified lysate was 
then loaded onto a prepared nickel column.  The nickel column was then washed using 
buffer A (50 mM potassium phosphate- pH 8.0, 300 mM KCl and 20 mM Imidazole) for 5 
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CV’s.  Next a gradient elution was setup to go from 100% Buffer A to 100% Buffer B (50 
mM potassium phosphate pH 8.0, 300 mM KCl, 250 mM Imidazole) in 30 minutes at a 
flow rate of 1 min/mL. During elution 2 mL fractions were collected and monitored for 
absorbance at 280 nm.  The fractions containing WT-CAP were then concentrated and 
buffer exchanged into 50 mM potassium phosphate pH 6.0, 500 mM KCl, 1mM DTT.  
WT-CAP was concentrated to 1 mM. 
CAP binding to sonicated salmon sperm DNA with and without DNase – CAP was used at a 
concentration of 500 µM for all NMR experiments.  An initial 1H-15N HSQC was collected 
and then sonicated salmon sperm DNA was titrated incrementally to be at 50 µg, 100 µg 
and 250 µg total DNA.  At each point a new 1H-15N HSQC was collected.  To test the role 
of cAMP in DNA binding a 500 µM CAP sample containing 250 µg of DNA was used.  
cAMP was titrated in going upto 1 mM CAP (3.37 µM, 4.35 µM, 9.4 µM, 50 µM, 250 µM, 
500 µM and 1 mM). A 1H-15N HSQC was collected at each point.  Finally to perform the 
clarified lysate experiment BL21 DE3 E. coli cells were grown in 5 mL LB media 
overnight.  The cells were then harvested at 4,000 x g for 10 minutes. These cells were 
then lysed using Bugbuster and the lysate was clarified at 15,000 x g for 30 minutes at     
4 oC.  WT-CAP was then added to 700 µL clarified lysate to a concentration of 500 µM.  
To digest the genomic DNA 25 µg/mL DNase was added to the sample and the sample 
was incubated for 10 minutes at 25 oC before collecting a 1H-15N HSQC. 
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In-cell NMR Spectroscopy of GB1 within E. coli 
 
Figure 43: Structure of GB-1 solved by NMR spectroscopy 
The in vitro structure of GB-1.  It forms a 4 stranded β-sheet where the inner two 
strands are parallel while the outer two are antiparallel with a α-helix on one 
side as shown. Β-strands are colored yellow while the α-helix is colored purple. 
 
The B1 domain of protein G (GB1) is a stable domain that binds the Fc of 
immunoglobulin G (IgG) (106).  This domain has 56 amino acids and is about 7 kDa.  It 
forms a 4 stranded β-sheet with a single α-helix (Figure 43). The two inner β-strands are 
parallel while the outer two β-strands are antiparallel.  Its stability has led to this protein 
becoming an NMR standard.  Thus this protein has been used for in-cell NMR 
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spectroscopy in E. coli (74), X. laevis oocytes (107)and HeLa (108) cells.  GB1 was used in 
E. coli for the first successful 3-D backbone assignment by NMR (74).   
Recently it has been proposed that only proteins that have an overall negative 
charge within the cell, by having a pI that is significantly lower than the native pH of the 
cytosol of the cell, which is around 7, will be visible by in-cell NMR spectroscopy within 
living E. coli cells (85).  This was reasoned to be the case due to the fact that 40-70% of 
native E. coli cells are also negatively charged along with the presence of the negatively 
charged nucleoid and cellular membrane.  Thus any negatively charged protein would 
be repulsed and thus tumbling relatively freely in solution while those proteins that are 
either uncharged or positively charged would have transient interactions with the 
negatively charged components of the cell thus causing them to have large apparent 
molecular weights and become invisible by NMR.  GB1 was used in this study as the 
example of the protein that has an overall negative charge, since its pI is 4.37, and is thus 
successfully detected within a live E. coli cell. 
To investigate this intriguing claim that only negatively charged proteins will be 
detected by in-cell NMR spectroscopy we placed a c-terminal 6-His tag onto GB1.  The 6- 
His tag raises the pI of GB1 to 5.54.  Based on the ranges reported (85) this classifies GB1 
as being a neutral charged protein and it should thus no longer be detected within a 
living E. coli cell by NMR.  We grew cells expressing either GB1 or GB1-His and 
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collected 1H-15N HSQC’s (Figure 44).  The untagged GB1 was easily detected by in-cell 
NMR spectroscopy while the GB1-His was not detected (Figure 44).  To verify that the 
inability to detect GB1-His was not due to poor protein expression the cells were lysed 
by sonication, the insoluble debris removed and a 1H-15N HSQC was collected.  There 
was sufficient expression for detection by NMR (Figure 44).  These results suggest that 
indeed the charge of the protein will affect the ability to detect a protein within a living 
E. coli cell.  These results also suggest that rather than the overall charge of the protein 
affecting in-cell NMR detection a localized charge, as the 6-His tag on GB1 really is a 
localized positive charge, can affect detection. This observation would suggest that if a 
protein were designed in such a way that the surface it presented to the cell were 
negatively charged detection may become possible.  Further studies would include 
adding other tags to the terminus of GB1 that span the range of charges, such as adding 
a 6-Lys tag, a 6-Ala tag or a 6-Asp tag to have a positive, neutral and negatively charged 
tag.  The detection or lack of detection would aid in understanding how charge affects 
in-cell NMR detection.  Finally, proteins that are known to be invisible, such as ubiquitin 
or FKBP, should be designed to present themselves as negatively charged and in-cell 
NMR experiments collected. 
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Figure 44: In-cell NMR Spectroscopy using GB1-His 
Various 1H-15N HSQC spectra of GB1.  The top left spectrum illustrates the 
fingerprint of GB1 in vitro as a reference spectrum for the in-cell NMR spectra.  
The top right spectrum was collected on E. coli cells expressing GB1 while the 
bottom left spectrum was collected on E. coli cells expressing GB1-His.  The 
bottom right spectrum was collected using the cleared lysate from the sample 
that was used to collect the bottom left spectrum illustrating that expression level 
of GB1-His was sufficient for detection by NMR. 
 
 
In-cell NMR Spectroscopy of Ubiquitin within E. coli 
 Ubiquitin is a 76 residue, 8 kDa protein that is ubiquitous in almost all eukaryotic 
cells.  Ubiquitin is best known for its role as the modification to other proteins that 
indicates that the tagged protein should be taken to the proteasome for degradation.  
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This degradation signal requires that polyubiquitin chains, consisting of at least 4 
ubiquitins, are formed through lysine 48 linkage of ubiquitin.  Ubiquitination can also 
signal many other pathways via either lysine 63-linked polyubiquitination or  
 
Figure 45: Crystal Structure of Ubiquitin 
The in vitro structure of Ubiquitin.  It consists of a mixed β-sheet, one α-helix and 
a short piece of 3(10) α-helix. Image was generated in Pymol using PDB ID: 
1UBQ (109). 
 
monoubiquitination. Some of the cellular processes that ubiquitin is involved with 
include: endocytosis, DNA repair, vesicular trafficking and signaling pathways.  The 
overall structure of ubiquitin consists of a mixed β-sheet, one α-helix and a short piece of 
3(10) α-helix (Figure 45) (109).  While ubiquitin is most often thought of as interacting 
 111 
 
with proteins via covalent linkages, ubiquitin can also associate with proteins via non-
covalent interactions such as hydrophobic interactions.  These non-covalent interactions 
are used by two of the three classes of enzymes that are responsible for ubiquitination, 
the E1 and E2 families.  The E3 family is covalently linked to ubiquitin and is responsible 
for transferring this linkage to the target protein.  Non-covalent interactions occur 
between ubiquitin and other proteins via the hydrophobic patch that ubiquitin presents 
on the face of the mixed β-sheet that is not blocked by the α-helix (Figure 46).  Ubiquitin 
serves many functions within the cell and along with its small size has been identified as 
an interesting protein to study using in-cell NMR techniques.  To date ubiquitin has 
been reported to be detected by NMR spectroscopy within E. coli cells (73), Pichia pastoris 
(P. pastoris) (110) and HeLa cells (108).  To observe ubiquitin within HeLa cells the 
residues that comprise the hydrophobic patch were mutated to Ala.  These residues had 
to be mutated in order for ubiquitin signal to be detected in HeLa cells by NMR 
spectroscopy (108). The observation that ubiquitin can be detected within E. coli cells is 
currently an observation that only Burz et al (73) can make, other labs that have 
attempted to detect ubiquitin by in-cell NMR spectroscopy within E. coli have not been 
successful.  Gierasch et al (85) suggest that ubiquitin, which has a pI of 6.56, is neutrally 
charged within the cellular environment and thus will not be detected by in-cell NMR 
spectroscopy, which is what they observed (85). 
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Ubiquitin has many interesting biological roles and being able to detect ubiquitin 
within live cells by NMR spectroscopy would enhance the understanding of how 
 
Figure 46: Zoom in of the hydrophobic patch of ubiquitin 
Focus on the hydrophobic patch responsible for most non-covalent interactions 
that occur between Ubiquitin and its many binding partners.  Image generated in 
Pymol using PDB ID: 1UBQ (109). 
 
ubiquitin functions along with displaying the versatility that in-cell NMR spectroscopy 
has.  We therefore attempted to determine what is necessary to successfully detect 
ubiquitin within living E. coli cells.  We were incapable of detecting wild type ubiquitin 
within E. coli cells.  By following the exact protocol reported by Shekhtman et al (73), 
which includes freezing the cells after expressing protein but before collecting the  
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Figure 47: 1H-15N HSQC Spectra of 3A Ubiquitin 
1H-15N HSQC spectra of ubiquitin.  The top spectrum shows the ubiquitin 
spectrum from an in vitro sample while the bottom left shows a spectrum of 
ubiquitin collected using live E. coli cells that are expressing ubiquitin.  The 
bottom right panel shows the spectrum obtained after lysing the cells used to 
collect the bottom left sample. 
 
desired NMR experiment, a spectrum of ubiquitin can be obtained.  Freezing cells is a 
well-known cell lysis technique and in our hands we detected ubiquitin in the 
supernatant however, Shekhtman et al report that their supernatant is clear.   
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 To detect ubiquitin within living HeLa cells by NMR Inomata et al (108) had to 
mutate the three residues that make the hydrophobic patch on ubiquitin to Ala.  We 
created the same triple mutant of ubiquitin, expressed the protein and collected a 1H-15N 
HSQC.  We did not detect any signal from ubiquitin (Figure 47).  We then lysed the cells 
from that sample and collected a 1H-15N HSQC on the cleared lysate.  The expected 
spectrum of ubiquitin was observed indicating that sufficient expression of ubiquitin 
was achieved, thus suggesting that an interaction within the cell is causing signal 
attenuation of ubiquitin.   
 Finally, it has been shown that ubiquitin will aggregate in the presence of copper 
(111).  The concentration of copper in the modified M9 minimal media is sufficiently 
high that it could potentially be causing ubiquitin to aggregate within the cell thus 
causing a large apparent molecular weight and signal attenuation.  3A ubiquitin was 
therefore grown and expressed in modified M9 minimal media that had no copper and 
used to collect a 1H-15N HSQC.  No ubiquitin signal was detected however ubiquitin was 
detected in the cleared lysate thus indicating that sufficient expression was achieved 
(Figure 48).  These results suggest that the ability to detect ubiquitin within live E. coli 
cells is not well understood and further studies of the exact parameters for reproducing 
Shekhtman et al’s results need to be conducted.  The final difference between the 
experiments resides with the promoter system that has been used.   
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Figure 48: 1H-15N HSQC spectra of 3A ubiquitin grown in M9 minimal media lacking 
copper. 
1H-15N HSQC spectra of ubiquitin.  The left shows a spectrum of ubiquitin 
collected using live E. coli cells that are expressing ubiquitin and have been 
grown in minimal media lacking copper.  The right panel shows the spectrum 
obtained after lysing the cells used to collect the bottom left sample. 
 
For our studies we induced expression using the T7 promoter while Shekhtman et al 
used the arabinose promoter.  The arabinose promoter tends to be a weaker expression 
system thus it is possible that the T7 promoter system is producing too much protein, 
thus causing non-specific interactions between ubiquitin monomers leading to signal 
attenuation.  Finally, this also suggests that careful controls must be done and that all in-
cell NMR experiments should be include a cell viability assay to ensure that the majority 
of cells are viable.  It is highly recommended that cells intended to be used for 
performing in-cell NMR experiments not be frozen prior to collecting the in-cell NMR 
experiment as this can lead to cell lysis and protein being present in the supernatant. 
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In-cell NMR Spectroscopy of EGFP within E. coli 
 Green Fluorescence Protein (GFP) is a 238 amino acid, 27 kDa protein that was 
originally identified from the jellyfish Aequorea aequorea (112).  This protein will fluoresce 
green when it is excited by blue light.  In contrast to most fluorescent and luminescent  
 
Figure 49: GFP X-ray structure 
The structure of GFP, a β-barrel consisting of 11 β-strands and six α-helices.  The 
chromophore, 4-(p-hydroxybenzylidene)imidazolidin-5-one (HBI), resides 
between the 2nd and 3rd α-helices.  The zoomed in window illustrates where the 
backbone cyclizes to form HBI. Image of GFP created in Pymol using PDB ID: 
1GFL (113). 
 
proteins GFPs fluorescence capability originates from the protein structure rather than 
an acquired cofactor.  GFP forms a β-can structure with six α-helices (113).  Residues 
Ser65 and Gly67, which reside between the second and third α-helices, will cyclize along 
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the backbone and Tyr66 gets oxidized to form the chromophore, 4-(p-
hydroxybenzylidene)imidazolidin-5-one (HBI) (Figure 49) (114).  Enhanced GFP (EGFP) 
is a variant of GFP that has three point mutations, F100S, M154T and V164A (115).  
EGFP is commonly used in cellular biology as a tag to localize other proteins via 
fluorescence microscopy techniques.  EGFP has been shown through many cellular 
biology studies to not interact with other molecules within a cell, thus allowing the 
conclusion that where fluorescence from EGFP is observed will be due to the localization 
of the protein that EGFP has been fused to (114).  Since EGFP does not interact with the 
components of the cell or with other proteins it should be favorable for 3-D structural 
studies of a higher molecular weight protein by in-cell NMR spectroscopy. 
EGFP was overexpressed in E. coli BL21 DE3 cells using the pGLO vector (Bio-Rad, 
Hecules, CA) and the arabinose promoter.  EGFP was expressed overnight at 15 oC to 
ensure proper folding in 15N modified M9 minimal media.  A 1H-15N HSQC was 
collected.  No signal for EGFP was detected (Figure 50) so the cells were lysed and a 1H-
15N HSQC collected however there was still no signal detected from EGFP.  This 
suggests that either the concentration of EGFP is not sufficient, EGFP is dimerizing with 
itself (EGFP has a weak dimerization tendency at concentrations above 5 mg/mL) and 
the 54 kDA dimer weight is leading to signal attenuation or EGFP is interacting with 
other cellular components that are causing a large apparent MW and thus leading to 
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Figure 50: 1H-15N HSQC spectra of EGFP 
1H-15N HSQC spectra of EGFP.  The top spectra shows the in vitro 1H-15N HSQC 
spectra for EGFP (116).The bottom left shows a spectrum of EGFP collected using 
live E. coli cells that are expressing EGFP.  The bottom right shows the spectrum 
obtained after lysing the cells used to collect the bottom left sample. 
 
signal attenuation.  The tendency to dimerize can be abolished with a single point 
mutant, A206K.  Thus a variant of EGFP, mYPet, was kindly provided by Dr. Harold 
Erickson’s lab.  This variant is induced using the T7 promoter system, which is a 
stronger promoter than the arabinose promoter, and should express greater amounts of 
mYPet compared to EGFP.  The same expression protocol and NMR experiment was 
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performed and once again no signal was detected (Figure 51).  Upon cell lysis no mYPet 
signal was detected (Figure 51).  This suggests that either the protein concentration is 
 
Figure 51: 1H-15N HSQC spectra of mYPet 
1H-15N HSQC spectra of mYPet.  The left panel shows a spectrum of mYPET 
collected using live E. coli cells that are expressing mYPET.  The right panel 
shows the spectrum obtained after lysing the cells used to collect the left sample. 
 
still too low for detection by NMR or that GFP is interacting with some cellular 
component leading to signal attenuation.   
To ensure that GFP was indeed expressing and not localizing within the cell 
fluorescent images of E. coli cells expressing EGFP were taken using a fluorescent 
microscope.  These images illustrated that EGFP was indeed expressing, folding 
correctly and not localizing within the cell (Figure 52). Considering the standard use of 
attaching GFP to proteins in vivo and using the fluorescence of GFP to localize where the 
other protein is found within a cell and the fairly low expression levels detected on an 
SDS-PAGE gel the most likely explanation is that the expression level of EGFP is too low 
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Figure 52: Microscopic images of E. coli expressing EGFP 
Microscopic images taken with a fluorescent microscope.  A) A differential 
interference contrast (DIC) image of E. coli cells B) Fluorescent image of the same 
cells as in A. 
 
for in-cell NMR detection.  Therefore, to observe GFP within live E. coli by in-cell NMR 
spectroscopy the expression levels of GFP will need to increase. Varying the amount of 
IPTG used for the mYPet expression and increasing the length of time the cells are 
grown before harvesting are two methods of optimizing protein expression that have 
not yet been pursued.  
 
In-cell NMR Spectroscopy of CAP within E. coli 
Catabolite activator protein (CAP) is a 209 amino acid, 22.5 kDa protein native to E. coli 
that functions as a symmetric homodimer.  CAP consists of two domains, the DNA 
binding domain and the cAMP binding domain (Figure 53).  CAP is a transcriptional 
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activator that interacts with over 100 different promoter regions by binding to its 
consensus DNA recognition sequence, 5’ - ATGTGATCTAGATCACATTT – 3’.  CAP  
 
Figure 53: Apo Catabolite Activator Protein (CAP) NMR structure 
The structure of CAP revels that there are two domains, the cAMP-binding 
domain (blue) and the DNA binding domain (red).  When cAMP binds the coil 
region, shown within the black box, will clamp down on cAMP which causes an 
α-helix leading to a 60o rotation of the DNA binding domain, thus allowing α-
helix F to align with the major grooves (117). This image was made in Pymol 
using PDB ID: 2WC2 (117). 
 
utilizes 3’- 5’ adenosine monophosphate (cAMP) for its mechanism of action.  When 
CAP is in its apo form it does not bind to DNA.  However, upon binding of cAMP to 
CAP the c-terminal domain rotates about 60o with respect to the N-terminal domain thus 
allowing CAP to bind to its specific DNA recognition sites near promoter regions  
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Figure 54: Comparison of Apo CAP and cAMP-CAP Structures 
Overlay of the Apo (Orange) and cAMP (Light purple) bound structures of CAP. 
A) Overview of entire complex illustrating that in the Apo form α-helix C is 
unfolded at its c-terminus compared to the bound structure. This unfolding leads 
to a 60o rotation of α-helix F causing α-helix F to not be properly aligned for 
binding to DNA. B) Zoom on α-helix C.  C) Zoom on α-helix F.  The red boxes 
are illustrating where the differences between the two structures reside. (117, 
118) 
 
(Figure 54).  Once CAP has bound to DNA it will enhance the ability of RNA 
polymerase to bind with DNA and enhance transcription.  If this model is indeed the 
case then it should be possible to observe CAP in its apo form within live E. coli cells 
using in-cell NMR spectroscopy and then supply cAMP externally to the E. coli and 
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monitor changes in the 1H-15N HSQC spectra as the cAMP is taken up by the E. coli cells 
and CAP binds to DNA.  A similar in-cell NMR study was attempted using the 
methionine transcriptional repressor protein, MetJ.  This protein represses the met 
regulon in the presence of S-adenosylmethionine (SAM).  In this study it was not 
possible to detect MetJ within a living E. coli cell.  It was determined that the cause of 
signal attenuation is due to a constant non-specific interaction of MetJ with DNA which 
leads to an increase of the apparent molecular weight for MetJ (77). 
 The first experiment performed involved determining whether or not pure CAP 
would interact with non-specific DNA.  For this experiment pure 15N-labeled CAP was 
generated and used at a concentration of 721 µM.  A 1H-15N HSQC was collected. Next 
50 µg of sonicated salmon sperm DNA was added to the sample and another 1H-15N 
HSQC spectra was collected.  This process was repeated iteratively until 250 µg of 
sonicated salmon sperm had been added (Figure 55).  This experiment demonstrated 
that when CAP was in its apo form it would not bind in a significant manner to 
nonspecific DNA thus suggesting that an in-cell NMR experiment may be feasible.   
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Figure 55: 1H-15N HSQC titration of sonicated salmon sperm DNA into CAP 
Overlay of 1H-15N HSQC spectra collected during a titration of sonicated salmon 
sperm DNA into 15N-labeled CAP. 
 
Finally, CAP mixed with 250 µg sonicated salmon sperm DNA sample was 
mixed with a 1:1 ratio of CAP:cAMP to determine if adding cAMP to the mixture would 
promote binding of CAP to sonicated salmon sperm DNA (Figure 56).  Adding cAMP to 
the mixture significantly reduced the detected signal for CAP indicating that when 
cAMP is present CAP will bind to nonspecific DNA thus leading to an increase in the 
apparent molecular weight of CAP and a decrease in the signal from CAP by NMR.  
This would indicate that it may be possible to detect CAP within live E. coli cells by 
NMR spectroscopy in its apo form and once CAP is bound to cAMP, and thus  
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Figure 56: 1H-15N HSQC’s of CAP bound to sonicated salmon sperm DNA with or 
without cAMP 
1H-15N HSQC spectra of CAP. A) pure apo CAP B) CAP bound to 250 µg 
sonicated salmon sperm DNA C) 1:1 CAP: cAMP bound to 250 µg sonicated 
salmon sperm DNA 
 
interacting with DNA, will no longer be detected.  The final control experiment 
performed was to take unlabeled E. coli cells, lyse the cells, spin out the insoluble debris 
and add 15N-labeled CAP to the cleared lysate.  This sample was then used to collect a 
1H-15N HSQC (Figure 57).  The advantage of this experiment is that only CAP is 
isotopically labeled in the sample thus detection of CAP does not need to compete with  
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Figure 57: 1H-15N HSQC of CAP in unlabeled E. coli lysate 
A) 1 H-15N HSQC of 15N-labeled CAP in clarified lysate from unlabeled E. coli 
cells. B) 1 H-15N HSQC of 15N-labeled CAP in clarified lysate from unlabeled E. coli 
cells containing DNase. 
 
metabolites.  CAP was not detected in this sample.  The lack of detection may be due to 
non-specific DNA binding therefore deoxyribonuclase (DNase) was added to the sample 
to thoroughly degrade genomic DNA.  This strategy was used to demonstrate that MetJ 
interacted with DNA in a nonspecific manner constantly (77).  A 1H-15N HSQC of the 
DNase degraded CAP sample in clarified lysate sample did not detect 15N-labeled CAP.  
This would suggest that CAP is not interacting with DNA, however this particular 
control experiment needs further optimization before completely ruling out DNA as the 
reason for loss of signal.  This control experiment indicated that it would not be possible 
to detect CAP within a living E. coli cell thus an in-cell NMR experiment was not 
performed.  Further experiments, such as optimization of DNase degradation or 
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competition with CAPs’ specific DNA recognition sequence, need to be pursued to 
determine why CAP is not detected in the clarified E. coli lysate. 
Conclusions and Future Directions 
 In-cell NMR Spectroscopy is a technique that has been shown to be capable of 
detecting proteins within several different types of cells including E. coli, Pichia pastoris 
(P. pastoris), Xenopus laevis (X. laevis) oocytes and HeLa cells.  While several different cell 
types have been used the observed proteins within these cells overlap and only about a 
dozen proteins have been reported to be detected to any degree by in-cell NMR 
spectroscopy.  Many of the reported in-cell NMR protein spectra do not detect the 
expected number of peaks as compared to an in vitro spectrum but rather a subset of 
peaks, sometimes due to the need to use selective labeling schemes and other times due 
to other detection issues, such as sensitivity limitations, time constraints, apparent 
molecular weight changes, etc.  In-cell NMR Spectroscopy has been shown to be 
particularly astute at using 1H-15N or 1H-13C HSQC experiments to detect changes in a 
protein as it binds to other proteins, drugs or DNA, however this function is only 
successful if a 1H-15N or 1H-13C HSQC experiment can be detected for the protein of 
interest.  The parameters for successful protein detection within a living cell still need 
further understanding before this technique will be broadly applicable.  The recent 
hypothesis that a protein’s overall charge will determine the ability to detect a protein 
 128 
 
by in-cell NMR spectroscopy is of great interest.  In our observations we have shown 
that it is possible to detect GB1, which has a pI of 4.37, while it is not possible to detect 
GB1 with a six histidine c-terminal tag, which has a pI of 5.54.  The pI for ubiquitin and 
the 3A ubiquitin we created is 6.56, quite close to the pH of the E. coli cytoplasm of 7.0.  
The pI for EGFP and mYPet is 5.80 and for CAP is 8.38.  Thus for all of the proteins that 
we were unable to detect by in-cell NMR spectroscopy the pI is reasonably close to the 
pH of the E. coli cytoplasm.  None of these proteins will have a significant overall 
negative charge except for GB1, which we can detect.  This lack of overall negative 
charge may be leading to the proteins interacting via hydrophobic interactions, or in 
CAPs’ case possibly through electrostatic interactions as well since it will be overall 
positively charged, with other proteins in the cytoplasm in a nonspecific manner, which 
will lead to an increase in the apparent molecular weight and attenuate NMR signal.  To 
further investigate how the charge of a protein affects in-cell NMR detection the simplest 
experiment includes adding differently charged tags to the N and C terminus of GB1, 
such as a six alanine tag, a six aspartate tag and a six lysine tag.  These GB1 constructs 
could then be examined for detection by in-cell NMR spectroscopy. It would be expected 
that the neutral and negative tags would not affect detection of GB1 while the positively 
charged tag would cause signal attenuation.  Another interesting experiment would take 
any of these proteins, but probably start with ubiquitin, and alter the surface charge 
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such that the protein will present itself to the cell as a negatively charged protein 
regardless of its overall charge.  This would indicate if overall charge truly needs to be 
negative or if the protein just needs to appear to be negative.  In conclusion in-cell NMR 
Spectroscopy has the potential to be a powerful technique for studying protein structure 
but further gains in detecting proteins within a live cell need to be made before this 
technique is broadly applicable. 
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